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ABSTRACT 
 
DEVIN KERRY HUBBARD: Electroceutical Technology: Anti-inflammatory Effects of 40-
160 T/s Inductively Coupled Electrical Stimulation (ICES) in the Acute Inflammation Model 
(Under Direction of Robert G. Dennis) 
 
 Electromagnetic therapies (sic: electroceuticals) have been studied and used for many 
years as a treatment for many ailments including chronic and acute pain, inflammation, 
muscle atrophy, non-union bone fractures, as well as peripheral and central neuropathies
1
. 
Presently we seek to explore the realm of inductively coupled electrical stimulation (ICES) 
which is a subclass of pulsed electromagnetic field therapies (PEMFs) that uses rapidly 
changing electromagnetic fields to induce current flows in tissues. Such fields are 
hypothesized to act via various mechanisms. However, in the present we seek to clarify the 
often ambiguous and confusing literature regarding ICES mechanisms by conducting a 
scholarly review by which we then provide a dose reporting scheme for accurately describing 
the relevant parameters required to fully define ICES treatments. Based on our review and 
experience, we hypothesize that ICES requires very specific parameters to function 
appropriately. We seek to ascertain the efficacy of 40-160 Tesla/second (T/s) ICES 
stimulation as an anti-inflammatory therapy. A specific mechanism explored is the 
calcium/calmodulin (Ca/CaM) pathway implicated in the literature
2–9
. Our results bring into 
question the scientific methods of previously reported results by suggesting that nitric oxide 
levels in vitro fall below detection limits of commonly used methods for gauging Ca/CaM 
modulation by ICES. In an effort to elucidate the efficacy of ICES as an anti-inflammatory, 
we make use of the well-established carrageenan footpad edema (CFE) model in rats. The 
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CFE model provides a spontaneously-resolving, acute inflammation model with a very well 
understood progression and biochemical mechanism. Our results indicate that 40-160 T/s 
ICES provides statistically significant, repeatable CFE reduction (P < 0.05) as measured by 
plethysmometry with no observed detrimental side-effects. Further work should focus on 
elucidating mechanism, evaluating safety, and exploring other potential applications—such 
as treating chronic conditions. The present studies support ICES as having the potential to 
provide life-changing therapy to individuals suffering from acute inflammation and pain. 
Given carefully conducted research in the future, we feel that ICES may revolutionize 
modern medicine not only from a treatment standpoint, but from the standpoint of 
understanding basic human electrophysiology and biochemistry. 
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CHAPTER 1 : A HISTORY OF ICES 
Introduction 
 Over at least the past seventy years, many different forms of pulsed electromagnetic 
field (PEMF) therapy have been reported in the scientific literature. Among these, techniques 
that employ the use of inductively coupled electrical stimulation (ICES) therapy have been 
reported in peer-reviewed scientific literature as an effective means of reducing pain and 
inflammation in a wide variety of conditions while often promoting healing
3,10–16
. Other 
forms of PEMF therapy have also been reported as effective, such as transcutaneous 
electrical nerve stimulation (TENS), however, the focus of this work will be on ICES rather 
than on other forms of PEMF treatment because of the many advantages of ICES. 
One conceptual advantage of the use of ICES over other types of PEMF technology is 
that it does not require the assumption that magnetic fields themselves interact directly with 
living tissues by means of some form of magic, or a complex and poorly-understood 
quantum physical effect.  Rather, the pulsed magnetic fields of ICES act through the well-
understood physical mechanism of electro-magnetic induction, wherein the external pulse 
generator uses non-invasive electric coils to create time-varying magnetic pulses that 
penetrate living tissue essentially without any strong direct interactions because the living 
tissue is essentially “transparent” to the magnetic fields themselves.  These pulses are 
inductively coupled across space to the structures within living tissues that have conductive 
paths, for example around the cell membrane in the paracellular space, or around organelles 
within cells.  These conductive paths within the tissue act as the “secondary” coil of what can 
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essentially be viewed as an air-core electrical transformer, the primary coil being the external 
ICES.  Based on the well-understood Law of Induction, one of the four classical Maxwell 
Equations, electrical currents are induced in and around the cells within the living tissue 
within the conductive paths in and around cells.  This takes the form of ions in solution being 
forced to move, driven by the induced fields
1
.  Thus, ICES is essentially a means by which 
electromagnetic induction allows the electrical stimulation of deep living tissues without 
requiring the use of invasive electrodes.  For this reason ICES has advantages over the much 
more common use of direct conductively coupled electrical stimulation, sometimes 
designated TENS.  Even though the scientific literature strongly supports the effectiveness of 
treatments such as TENS, ICES has several other very important advantages over direct 
methods. For example, ICES does not have to overcome the resistance of skin tissue, and the 
induced fields generated in deep tissue by ICES-based systems are more widely and more 
uniformly distributed across the tissues being stimulated. TENS stimulation energy generally 
follows the path of least resistance, resulting in highly non-uniform energy distribution 
within the tissues being stimulated.  One final advantage of ICES over more general forms of 
PEMF stimulation is that when properly applied, ICES pulses are transformed into induced 
electrical signals that themselves mimic known electrical signals within living tissues, such 
as those involved in excitation-contraction coupling of striated muscle (skeletal and cardiac 
muscle), therefore ICES can take advantage of native signal reception and amplification 
mechanisms within living cells/tissues, thus requiring only very low stimulation energy to 
achieve the desired cellular response.  For these reasons, the remainder of this dissertation 
will focus on ICES rather than on other forms of PEMF. 
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The physics of ICES gives a clear and understandable mechanism by which electrical 
energy can be induced within deep tissues by the Law of Induction.  It remains to be 
elucidated how the induced fields are transduced into useful biological signals.  Observations 
and mathematical models suggest that one of the primary anti-inflammatory mechanisms of 
ICES is via the Calcium-Calmodulin (Ca
2+
/CaM) dependent nitric-oxide synthase 
pathway
2,5,7–9,17–21
. Specifically, it is hypothesized that electromagnetic pulses of appropriate 
parameters will preferentially induce calcium binding to CaM
7
. Regardless of the 
mechanism, of utmost importance are the waveform parameters—with the most effective 
parameters reportedly falling within a range producing induced electrical fields on the order 
of 1 V/cm
7,22
. 
Unfortunately, the majority of the PEMF and ICES literature fails the basic scientific 
requirement of repeatability. By our accounting, more than 90% of all published reports fail 
to include adequate waveform parameters to fully define the dosimetry of the applied 
treatment. This shortcoming in the literature is very unfortunate as it tends to drive reputable 
clinicians and scientists away from the scientific study and clinical acceptance of PEMF in 
general and ICES specifically, even though there is strong evidence to suggest that ICES, 
when properly applied, is safe and can be very effective at reducing inflammation and pain 
while also accelerating healing of otherwise refractory injuries. 
Herein we seek to review past and current technologies, effective waveform 
parameters, and propose a summary of the current theories regarding the mechanism of 
ICES. Our goal is to establish clearly those experiments which are properly executed and 
have well-described stimulation parameters, and show that ICES is an effective treatment for 
pain and inflammation given the appropriate stimulation waveforms. 
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The concept of using pulsed electromagnetic fields (PEMF) has been explored as a 
clinical therapeutic since the 1950’s12–14,23–25. Since then, PEMF has been used to treat 
critical bone-gap defects (including spinal non-fusion), wound healing, inflammation, as well 
as various psychiatric disorders
1–3,6,7,9–16,20,22,25–64
. Macroscopically, there are no properties 
that would warrant the expectation that a static magnetic field would interact directly with 
tissues (as can be demonstrated by the fact that a static magnetic field can pass nearly un-
attenuated through tissue). However, there is reason to expect that a changing magnetic field 
would (and will) interact with any medium in which there are charge carriers—including 
tissues—to produce a flow of charge. Given that all biochemical interactions—from enzymes 
binding ligands to ions flowing through membranes—are driven by electrostatic interactions, 
it follows that a rapidly changing electromagnetic field should induce flow of current in 
tissues in the form of movement of ions that could have effects on the binding interactions of 
biochemical compounds. It is also very well established that tissues are constantly exposed to 
electrical fields, and that electrical fields play a key role in bio-signaling. Thus, because we 
hypothesize that the efficacy of PEMF is due to its inductive electrical signal within tissues, 
we prefer to use the term inductively coupled electrical stimulation (ICES) rather than 
PEMF. A second reason to use the term ICES is that the term PEMF has been used widely in 
a large body of literature that paints a less than replete picture of mechanism and effects. 
There is simply too much negative attention drawn to PEMF because most investigators do 
not understand that both PEMF and ICES should only work within a very specific range of 
stimulation parameters
7,18,19
, namely those that induce signals that can be interpreted by 
existing signaling mechanisms within cells and tissues Our research in muscle tissue 
engineering has established similar results, showing that only in a particular range of 
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stimulation parameters can one successfully provide signals to which tissues will respond in 
a favourable way. Herein, we seek to provide objective evidence that ICES, when applied 
appropriately, can provide significant and repeatable anti-inflammatory effects in an acute 
inflammation animal model. 
Background 
 Electromagnetic therapies have been in use for many years. Electrical stimulation of 
tissues has been studied since Galvani’s experiments using electricity to stimulate contraction 
of the muscles in dissected frog legs
65
. The systematic study of the effects of electrical and 
magnetic fields on living and dead tissues began with Galvani in the late 18
th
 century, whose 
research led to the discovery that one of the primary methods of information transfer within 
nerve and muscle tissues is via electrical pathways. In the middle of the 20
th
 century, it was 
discovered that bone is piezoelectric in nature, and therefore was hypothesized to also 
transduce information electrically
23,24
. Soon thereafter, many experiments demonstrated that 
directly-applied electrical currents can be employed to induce bone formation and 
remodeling
12–14,25
. One problem with these early methods of direct electrical stimulation of 
bone tissue was that they required the implantation of electrodes into and around the bones to 
be stimulated. The deeply invasive nature of direct electrical stimulation of bone lead to the 
development of non-invasive methods, such as the use of induced electrical fields. These 
inductive methods employ magnetic fields from external magnets or solenoids that change 
over time to induce the desired electrical fields within the tissues, based on the well-
understood Faraday’s Law of Induction66. Electrical fields induced in this non-invasive 
manner were subsequently shown to be effective in eliciting accelerated bone formation and 
healing
12
. With the advent of inductive stimulation methods came the study of the effects of 
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non-depolarizing electromagnetic fields on tissues other than bone. Non-depolarizing electric 
fields are those which are too low to induce overt depolarization of the cell membrane as in 
the case of an action potential, but strong enough to presumably have other effects on 
molecular mechanisms within cells and in the extracellular space. Such mechanisms have 
been widely hypothesized to mediate the signals involved in functional adaptation of 
musculoskeletal tissues, and are the subject of ongoing mainstream scientific research. These 
signals are generally thought to be very small in magnitude compared to action potentials in 
excitable tissues, and many competing mechanisms have been hypothesized. 
Nerve regeneration is also thought to be subject to similar signaling mechanisms that 
induce accelerated healing and repair as it was shown that non-depolarizing electromagnetic 
pulses could improve nerve lesion healing. Further studies showed that inflammatory factors 
could be reduced in tissue inflammation in humans post operatively
10,11
. Pilla and colleagues 
developed a theory of interaction between pulsed radio frequency (PRF) waves and tissues 
which makes use of the frequency response of tissues and places lower bounds on waveform 
parameters based on the thermal noise threshold
2,4,5,7,17–19,67,68
. More recently, ICES has been 
studied in terms of behavioural modulations—specifically the effects of ICES on bipolar-
disorder, autism spectral disorder (ASD), Alzheimer’s, and Parkinson’s disease29–37,46. Prior 
to discussing the effects of ICES on cells, tissues and systems, it is necessary to discuss the 
important parameters which govern how tissues will respond to electromagnetic radiation. 
Types of biologically relevant signals 
There are three key levels of signals that need to be specified in order to properly define 
the waveform parameters that are to be used when inductively stimulating:  
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1. Current flowing into the coils from the stimulation unit. This is the original driving 
signal that is produced by the electronic circuit within the ICES device to drive the 
coil that will then produce the magnetic field. 
2. The time-varying magnetic flux in and around the coils resulting from the electrical 
current driving the wire coils. 
3. The induced electric field in the tissue volume resulting from the time-varying 
magnetic flux generated by the coils. 
Based on our detailed review of the literature, we have determined that in most cases 
investigators report only a partial description of the original driving signal emanating from 
the electronic circuit (#1 above), but do not measure, calculate, report, or estimate the 
resulting magnetic field vs. time (#2 above) or the electrical fields that are ultimately induced 
within the target tissues (#3 above). For the most part, the second level signal—magnetic 
flux—is the most relevant signal to specify because it is prone to deviate from theoretical 
values when calculated based upon the presumed driver circuit performance, it is readily 
measured using modern analog signal Hall effect sensors, and when measured accurately 
yields good estimates of the induced field within the tissues. It should be noted that it is the 
final signal—the electric field induced within the tissues—which is the hypothesized 
mediator of the responses seen in vivo and in vitro, but that it is difficult to directly measure 
these induced fields within tissue.  
Current flowing into the coils (primary or first-level signal) 
In time-varying magnetic field stimulators it is the primary signal from the electronic 
device that drives the coil(s) to produce the magnetic field. For the purposes of this 
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discussion we will not consider “static” magnetic devices such as permanent magnets or 
solenoids driven by steady DC current. In static cases the magnetic fields are largely steady 
and non-varying over time, so their ability to induce electrical fields is essentially zero 
because the first time derivative of the magnetic flux in steady magnetic fields is by 
definition equal to zero. That is not to say that such devices would have no biological effects, 
because they certainly may have effects through such mechanisms as the Hall Effect, in 
which charged particles (ions) ubiquitous in biological systems would be influenced as they 
move through the steady magnetic field. The induction of electrical fields within tissues 
requires magnetic fields that vary in time, and typically this is accomplished using a 
computer or a microcontroller-based platform to drive current waveforms through solenoid 
coils. To induce the desired electrical fields it is essential to control the slew-rate (rate of 
change or first time derivative of the magnetic flux) of the signal. Thus, it is of utmost 
importance that the primary driving electronics have adequate dynamic performance. 
However, since most investigators do not measure or report the second- or third-level signals 
(above) they generally cannot guarantee that the primary driver electronics have adequate 
dynamic performance to achieve the desired biological effect. The primary signal also allows 
one to determine the upper limit of the overall stimulus signal power. Basically the maximum 
power into the system can be calculated by knowing the maximum current flowing into the 
coils and the impedance of the coils (though empirically, the power transfer to the body is 
much lower because of inefficiency). Because the undesirable effects of non-ionizing radio 
frequency (RF) energy generally are regarded to arise from thermal effects within the tissue, 
it is conservative and correct to consider the total ICES system power when determining the 
upper limit of potential harmfulness of any ICES or RF stimulation system, and the power 
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consumption of the primary driving electronics provide a direct and convenient opportunity 
to measure and determine the upper boundary for power for the entire system. 
Magnetic flux produced by coils (secondary or second-level signal) 
Because there are electrical (Ohmic and reactive) energy losses in driving the primary 
signal through the coils, it is most accurate to directly measure the dynamic magnetic flux 
produced by the current flowing into the coils. From these measures one can disregard the 
need to correct for dynamic limitations of the primary driver circuit, and the induced electric 
field within the tissues can be more accurately estimated. Faraday’s law of induction shows 
that the induced circular electric field in a conducting surface is proportional to the inverse of 
the rate of change of the magnetic flux (defined as the magnetic field strength times the area 
through which it is passing). The key parameters involved with the induced electric field are 
the rate of change of the magnetic field (i.e. dB/dt, which is the first time derivative of the 
magnetic flux B) and the radius around which one examines the field of interest. Specifically, 
the larger the rate of change of the magnetic field, the larger the possible induced electric 
field. Maxwell’s relationship explains why the driving electronics must have good dynamic 
performance: to provide adequate magnetic flux slew rate to induce the desired electric field 
in the tissue. For a given magnetic flux change, the larger the radius of interest (up to the 
inner radius of the stimulating coil), the larger the induced field, and the smaller the radius, 
the smaller the induced field. The induced electric field for a Helmholtz coil decays linearly 
to zero within the boundaries of the coils and falls off as the inverse of the distance from the 
outer edge of the coil outside of the boundaries of the coils (Figure 1.1). The internal surface 
of the graph in Figure 1.1 is a cone, representing the induced electrical field strength between 
the coils where the induced electric field decreases toward zero linearly as the radius of 
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curvature of the induced field drops to zero in the x-y plane. The inner conical surface is 
perhaps most relevant because it is the volume of tissue between or within the coils that 
generally is intended to undergo treatment with ICES. 
 
Figure 1.1: Induced electric field caused by Helmholtz coils. (Left) Representative plot 
of induced (tertiary or third level) electric field strengths within a conducting surface as 
caused by a Helmholtz configured set of ICES coils. Any path within the circumference 
of the coils with radius less than the coils will have an induced electric field dictated 
only by its radius, not its axial position within the coils. Outside the circumference of 
the coils, the radius of interest must be concentric with the axis of stimulation in order 
for the plot above to apply. Note that the peak magnetic field is induced around a 
pathway of radius equal to the stimulating coils. (Right) Representative 2-dimensional 
slice of the surface on the left showing a cross section of the conical interior and 1/r 
behaviour of the induced (tertiary or third level) electric field in a conducting surface. 
The diameter of the representative coils is 50 mm and the plot is constructed for a 
magnetic flux slew rate of 80 T/s. 
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Induced electric field within tissues (Tertiary or third-level signal) 
Finally, it is necessary to discuss the induced electric field—specifically with regard 
to the tissue volumes of interest. The induced field can be calculated simply using equation 1 
below: 
  ( )    
  
  
 
 
        (1) 
For example, if one considers a stimulation volume on the order of 10 µm (average 
cell diameter), then with a magnetic flux slew rate of 1,400,000 Gauss/second (=140 
Tesla/second), a magnetic pulse will induce a peak electric field of approximately 3.5 x 10
-4
 
V/m around the perimeter of a typical cell. If one considers thermal noise averaging, and 
cellular response, then the predicted threshold induced field for a measureable response is on 
the order of 10
-3
 – 10-5 V/m 69. Thus, a 140 T/s stimulus should cause a measurable 
physiological response. Furthermore, assuming the low-end of the stimulation threshold to be 
approximately 10
-5
 V/m, the smallest signal that one might expect to use and still observe a 
physiological response is approximately 4 T/s. However, if one considers a conduction 
pathway on the order of the radius 35 mm (ex: the outer edge of a 6-well plate well), then the 
peak electric field produced by the same, 140 T/s magnetic pulse is on the order of 1.23 
V/m—well above the detection threshold for tissues. We would like to point out that in fact, 
the model being used to explain the induction of electric fields within a tissue volume is 
identical to the model of eddy currents
66
. In the case of eddy currents within a tissue, one can 
consider the conducting pathways to be represented by the fluid in the pericellular space, just 
outside the cell membrane and between cells and thus, circular pathways around cells are 
those of interest. Since there are many cells in a tissue mass, there are various conducting 
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pathways, some circular, but most are not. Considering that the field strength in a plane 
varies with respect to the radius of interest, one can determine that if cells meet in locations 
where the cross sectional radii are not identical, then the currents where the cells meet will 
not cancel, and there will be a net flow of current around the larger radius of interest. 
However, if two cells meet at a location such that their cross-sectional areas are 
approximately the same (and they are both relatively circular cross sections) then circular 
currents flow around each cell, and should approximately cancel where the cells meet—
producing a conducting path around both cells (Figure 1.2). Because of these geometric 
effects, it is possible that amplification effects might be seen for signals that fall below 
theoretically calculated stimulation thresholds. Such circumstances may dominate the 
geometry in tissues with relatively high cellular density such as muscle and skin in which the 
cells occupy well over 50% of the volume in any representative sample of tissue. In the case 
where cells are separated by relatively larger distances, the induced electric fields in the 
pericellular fluid spaces surrounding each individual cell may not interact as shown, each cell 
being subjected to an induced electric field. If all cells in the target tissue have approximately 
the same geometry, then each individual cell in the target tissue would be stimulated very 
nearly uniformly throughout the tissue within the coils. This geometry could dominate in 
tissues with relatively lower cellular density with widely distributed (not clumped) cellular 
arrangement, such as bone, tendon, all types of cartilage, ligament and crucially, the 
interfaces where these tissues meet 
28
. 
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Figure 1.2: A cartoon of the current flow induced around cells. Top.) Cells of equivalent 
radius have offsetting electric fields between them, resulting in a net current flow 
around the perimeter of both cells, but not between them. Bottom.) Cells of different 
radii of intersection will have a net current flow around their perimeter and in the 
direction between them determined by the larger cell. 
The above arguments generally hold true for the simplest of cell geometries: 10 
micron diameter spherical cells. Though this assumption of simple geometry may be 
adequate for many estimations of tissue properties, such as estimating the number of cells in 
a given volume of tissue, the spatial details of cell membrane geometry and receptor 
distribution may well dominate when considering the mechanisms that relate to 
electrochemical transduction and mechano-transduction in cells and tissues. The assumption 
of a simple and smooth cellular geometry thus runs the risk of falling into the scientific error 
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known as the "assumption of a spherical cow", which takes the form of a joke based upon 
commonly encountered scientific over-simplifications than make calculations easier at the 
cost of ignoring the most important details of the system being studied. Many cells in the 
musculoskeletal system are known to have a complex surface structure containing thin 
filaments that stretch out into the space between cells. For example, osteocytes (cells in bone 
tissue) are known to have cytoplasmic processes which extend into canaliculi (tiny canals) in 
the hard bone matrix
27,28
. These thin extensions of the bone cell membrane are known to be 
involved in the collection of nutrients and elimination of waste, but it is hypothesized that 
osteocytes may detect mechanical loads through the detection of signaling that arises from 
the mechanically-induced flow of fluids and ions through the lacuno-canicular network 
surrounding each osteocyte
27
. It is one of our working hypotheses that ICES systems work at 
this pericellular level to emulate the mechanical signals in musculoskeletal tissue systems 
that would normally induce a functional adaptive response, such as bone growth and 
remodeling to increase bone density as a result of exercise. We further hypothesize that the 
emulation of these signals by ICES stimulators has the added benefit of employing the 
natural signal amplification systems within the musculoskeletal system without actually 
applying the mechanical loads to the tissues being stimulated, thus allowing musculoskeletal 
tissues to adaptively respond to the emulated signals without also being subjected to the 
structural micro damage that would otherwise occur from the mechanical loads. 
ICES as a biological signal 
Biologically relevant signals often have the property of being very low-level; either 
very low amplitude, low energy, infrequent, or otherwise subtle. As a result, these signals are 
often difficult to detect experimentally. Through millions of years of evolution, the molecular 
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and cellular responsiveness to low-level signals has evolved in many cases to become highly 
specific and responsive only to a very precisely defined signal, so as to prevent amplification 
of spurious background noise that might elicit inappropriate cellular or molecular response. 
Within the receptive bandwidth of such low-level biological signals the signal itself must 
have a high signal-to-noise ratio (SNR), with minimal energy being expended upon 
parameters of the signal that do not contribute to the intended message. This evolved SNR 
allows all other signals that fall outside of the receptive bandwidth to be essentially ignored. 
The evolutionary process tends to make good use of such highly selective and efficient 
processes once they have passed the test of natural selection, so it is reasonable to 
hypothesize that a signal that might elicit a functional adaptive response in one tissue, for 
example bone, might also be employed by other tissues for similar purposes. This would be 
especially true for tissues within the same functional groups such as musculoskeletal tissues, 
cardiovascular tissues, nerve tissues, etc. On the basis of this reasoning we hypothesize that 
specific signals that induce tissue growth and regeneration in one tissue in musculoskeletal 
system might elicit the same general response in many or all other tissues of the 
musculoskeletal system. So a specific signal that is known to elicit acceleration of bone 
repair might also elicit accelerated repair in cartilage, ligament, tendon, and muscle as well. 
Our review of the literature reveals that this general assumption may be implicit, but is 
generally not explicitly articulated in the description of any of the ICES technologies that 
have been reported. In most cases we believe the ICES signals that are employed, often 
referred to as ICES "waveforms", have been arbitrarily selected and often not developed and 
refined based upon the aforementioned line of reasoning. Therefore many ICES technologies 
do not take advantage of the inherent natural mechanisms of biological signal amplification, 
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preferring instead to use a brute-force approach to coerce the target tissue toward the desired 
response rather than employing high fidelity signals that work with innate biological filters 
and amplifiers. The literature suggests that this latter brute-force approach, though crude, is 
in fact effective to a limited degree. However, such a crude approach has no basis from 
which to develop increasingly sophisticated, efficient, and effective ICES signals. Thus, most 
commercially-available ICES technologies simply are not improved over time. Once 
treatments can be demonstrated to be statistically significant in their intended biological 
effects, the evolution of the ICES waveform protocols toward increasingly better signals 
generally does not occur. This process of accepting the first guess that “works” is 
exacerbated by modern regulatory practices, such as those enforced by the FDA relating to 
medical devices.  Once a medical device has been proven “safe and effective”, it is 
exceedingly difficult and costly to make any changes to the stimulation parameters.  The cost 
of making even a slight change to PEMF or ICES parameters on an approved medical device 
can rise as high as $180M and can take from 3 to 5 years to complete because the entire pre-
market approval (PMA) process must be repeated for each change to any waveform 
parameters, according to current FDA policy related to PEMF devices, which have been in 
force since May 28, 1976.  [[I think I have an actual court case that you can include as a 
reference for this, I will search for it.]].  Imagine the chilling effect of similar regulatory 
restrictions on any other technology.  Imagine where computer technology would be if 
innovation were frozen in place by a federal regulatory agency such that computers proven to 
be “effective” in 1976 could essentially not be incrementally improved upon without.  In this 
regard, in addition to protecting the public against ineffective and or dangerous medical 
device technologies, FDA device regulations have also had the unintended consequence of 
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putting the “NO” firmly back into inNOvation.  This helps to explain why health and 
medicine have generally not enjoyed the same pace of technological progress that other non-
medical technologies have enjoyed for the past 4 decades, including computing, 
communication, entertainment, transportation, safety equipment, and basically every other 
aspect of our lives. 
The unintended consequence of this over-regulated, inefficient, and crude approach to 
the development of ICES waveforms has been that most ICES systems remain very 
inefficient, bulky, costly, and they subject the target tissue to unnecessary levels of 
electromagnetic energy. More rational approaches to ICES waveform design are certainly 
possible. 
ICES waveform shapes 
Many different methods exist for inducing an electric field within tissues and all of 
these have been employed at various times by different ICES systems. Waveforms can be 
divided into four distinct waveform categories: pure sinusoidal, 
triangular/sawtooth/trapezoidal/square, asymmetric pulses, and pulsed radio frequency 
(PRF)/Modulated signals. Stead (DC) magnetic fields will not be considered, though they are 
frequently employed, for the reasons stated previously. One must also keep in mind that there 
are three levels of signals, as discussed above. For the following discussion the signal 
waveforms refer to signals in level #2: the magnetic field generated by the coils. 
Sinusoidal waves 
Sinusoidal stimulation is by far the most common form of ICES stimulation, based 
upon a pure sinusoidal magnetic waveform. In the literature it is well established that tissues 
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typically respond to radio frequencies (RF) from 0 Hz to 10 kHz—outside of this range, 
tissues and cells are essentially transparent (with the exception of PRF signals). The smallest 
wavelength of such signals in an electrolyte environment is on the order of 3000 meters—
thus cells are unlikely to be acting as antennae at such frequencies. Furthermore, a frequency 
of approximately 30 THz would be required to induce resonance in a cell of size on the order 
of 10 µm in a saline solution. Interestingly, because tissues have been found to be responsive 
in such a low frequency range, one must consider the mechanisms by which cells or 
molecules might transduce these signals. Much of the biological response is dependent upon 
the bulk electrical properties of tissues (direct and reactive impedances), which dictate how 
electrical energy is absorbed through a medium. In the case of a magnetic field, because the 
vast majority of mammalian tissues are not known to interact with magnetic fields, one must 
consider magnetically induced electric field pathways as the primary method in which 
magnetic fields can interact with tissues. Because the induced electric field is proportional to 
the rate of change of the magnetic field, the amplitude and frequency of the magnetic field 
dictates the strength of the cellular response. Thus, higher frequency and amplitude signals 
should be more effective in eliciting a response. It should be noted that there is significant 
theoretical evidence that suggests that there is a lower bound for frequencies as well due to 
the thermal noise threshold
19,69,70
. Interestingly, there have been a number of studies that find 
effects well below the theoretical frequency and amplitude limits predicted mathematically, 
suggesting either a placebo effect or an alternative transduction mechanism
29–40,69,71
. 
Triangular/Trapezoidal/Square waves 
Triangular, trapezoidal and square waves fall into a similar category because they 
represent Fourier sums. While the multi-frequency aspect of such signals may be a reason 
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that they are effective, it may equally be the case that their efficacy is due to the high slew-
rates that can be produced. For practical purposes, pure square waves are impossible to create 
electronically: there is always a finite rise-time and fall-time for the primary electrical 
signals, they cannot change instantaneously. Thus, this category of three waveforms can be 
collapsed into triangle and trapezoidal, which includes square waves which are actually 
trapezoids because their rising and falling slopes are not perfectly vertical. Both triangular 
and trapezoidal waveforms provide bipolar induced fields, which depend upon the slope of 
the sides of each trapezoidal waveform—the main difference being that there is a delay 
between positive and negative peaks in a trapezoidal pulse given by the length of the signal 
plateau. 
Asymmetric pulses 
Asymmetric pulses are typically triangular or trapezoidal in nature, but have a 
differing rising and falling edge. Such waveforms can be useful for inducing non-equal 
bipolar induced electric fields. Examples of asymmetric pulses include saw-tooth waves such 
as those shown in Figure 1.3. 
PRF/Modulated signals 
Pulsed radio frequency (PRF) signals provide a high-frequency method for encoding 
low-frequency signals, similar to the way in which an FM radio works. Because tissues will 
integrate low-frequency signals (i.e. they act as a high-pass filter), they can demodulate 
pulsed PRF signals. The advantage of such a stimulation paradigm is that tissue penetration 
can be increased. Since radio frequency signals can penetrate tissues easily, PRFs can 
provide an effective means of stimulating deep tissues without using very strong external 
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fields. The efficacy of PRF stimulation has been explained by Pilla et al. on the grounds of a 
proposed biochemical model
2,3,5,7,10,18,19,68
. Under appropriate stimulation parameters, PRFs 
can modulate first order kinetics of ion binding to enzymes. Pilla’s work is focused on 
modulating calcium binding to calmodulin in vivo—providing a method by which 
downstream targets such as endothelial nitric oxide synthase (eNOS) and neuronal nitric 
oxide synthase (nNOS) can be affected
7
. 
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Figure 1.3: Representative ICES waveforms. A.) Sinusoidal waveforms have smoothly 
varying edges, and can also be pulsed at high frequencies to produce PRF signals. B.) 
Trapezoidal and square waveforms represent waveforms with large rising and falling 
edge slopes and non-changing peaks and troughs. C.) Asymmetric pulses, such as the 
saw-tooth waveform shown, represent waveforms that have large rising and/or falling 
edge slopes, but provide non-symmetric induced electric fields within tissues of interest. 
A description of the numbered portions above can be found in Table 1-1. 
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Table 1-1: Summary of important descriptive ICES waveform parameters. All 
numbered items are labeled in Figure 1.3 on their respective waveform type letter. 
Unlabeled components are those which cannot easily be drawn on a figure, however are 
absolutely necessary. Trapezoidal waveforms are assumed to be constructed of straight 
lights—if lines are curved, a function may be required to define the edge slopes. It 
should be noted that this table is not comprehensive, as more complicated waveforms 
may require additional information to fully define one full cycle of stimulation. 
Summary of Important Secondary Wave Structures Necessary for Fully Defining ICES 
Waveforms 
Sinusoidal 
(A) 
PRF (A) Trapezoidal (B) Asymmetric Pulse 
(C) 
Period (1) 
Amplitude (2) 
Peak Slope 
Bulk Pulse 
characteristics 
Carrier Period (3) 
Amplitude (2) 
Encoded frequency 
Peak Slope 
Pulse rate (pps) 
Amplitude (2) 
Positive Rising Edge Slope 
Positive Rising Edge time (4) 
Time at Max (5) 
Positive Falling Edge Slope 
Positive Falling Edge time (6) 
Time at Zero (7) 
Negative Falling Edge Slope 
Negative Falling Edge time (8) 
Time at Minimum (9) 
Negative Rising Edge Slope 
Negative Rising Edge time (10) 
Peak Slope 
Pulse rate (pps) 
Period (1) 
Amplitude (2) 
Rising Edge Slope 
Rising Edge time (4) 
Falling Edge Slope 
Falling edge time (6) 
Peak Slope 
Pulse rate (pps) 
 
 
 
 
 23 
 
Waveform parameters 
All waveform categories and shapes are defined by a set of waveform parameters. 
These include amplitude, frequency, slew rate, and other parameters. Some waveforms are 
well described by only two parameters, such as continuous pure sine waves which can be 
defined by the two parameters amplitude and frequency. Other waveforms are more complex 
and may require six or more parameters for a complete description. An example of this is 
asymmetric trapezoidal waves that are generated in short bursts of pulses followed by periods 
of no stimulation. In this case the waveform would be fully defined by at least twelve 
parameters: start time, initial slope, peak amplitude, duration (time) held at peak amplitude, 
final slope, terminal amplitude (can be zero or have opposite sign for bipolar pulses), 
duration of zero or opposite-sign plateau, return slope (if non-zero), time between pulses, 
number of pulses in each burst, dwell time between bursts, and at least one additional 
parameter to define the periodicity of the bursts of asymmetric trapezoidal pulses.  
Amplitudes 
The mechanism for the biological effects of ICES as they relate to magnetic flux peak 
amplitude, and thus the relative importance of this parameter, remains slightly ambiguous at 
this point because there is a large range of experimentally effective amplitudes that fall well 
below thermal noise limits. However, generally speaking, larger amplitudes are more 
effective in direct tissue stimulation until high amplitudes that begin to cause collateral tissue 
damage are reached. This damage is most likely because more energy is dissipated into the 
tissues in each unit of time. Energy per unit time yields the physical units of power, and 
electromagnetic power is associated with tissue damage when the power level begins to reach 
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a level with significant thermal effects within the tissue. This effect is put to positive use in 
modern surgery when radio ablation is utilized to destroy tumors or other unwanted tissues. 
Assuming that the RF power is below a damaging level, we have noted in a wide variety of 
literature that induced electric fields on the order of 0.01 – 10 V/m appear to be most 
effective in treating chronic pain and inflammation. Generating such field strengths can be 
done using several magnetic waveforms. It should also be noted that much lower amplitude 
magnetic fields, on the order of picotesla, (10
-12 
T) have been reported to be clinically 
effective for treatment of multiple sclerosis and Parkinson’s patients29–40. So, one can 
conclude that waveform amplitude certainly plays a role in both the efficacy and the potential 
risk involved in the use of ICES stimulators, but the precise role and the underlying 
biological and electromagnetic mechanisms remain to be elucidated. 
Frequency 
The waveform frequency parameter is also considered of vital importance when 
considering periodic signals. The precise role of frequency is somewhat obfuscated by the 
imprecise use of this very well-defined engineering term. As noted previously, tissues 
typically only respond to frequencies below 10 kHz, with the exception being that FM 
signals can be demodulated by tissues, provided the low frequency encoding falls below 10 
kHz. Because the frequency of a sinusoidal magnetic flux signal dictates the time derivative 
dependence, and therefore the induced electric field magnitude, it follows that higher 
frequency signals are capable of inducing electric fields with greater peak amplitudes in the 
target tissue. However, as we shall see later, there are theoretical limits that help narrow 
down the range of frequencies that would be theoretically effective. For example, a 1 Hz 
wave would require a peak amplitude of approximately 100 tesla in order to induce an 
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electric field on the order of 1.75 V/m around the perimeter of a 35 mm disk. This peak field 
strength is approximately 100 times higher than the average field produced in a clinical MRI 
unit, which is a very large amplitude indeed. One tesla = 10,000 gauss, so a 100 T field = 1 
MG, which is about 1.5 million times the average magnetic field strength of the Earth. At 
higher frequencies the calculus, a simple derivative of the sinusoidal waveform, indicates that 
significantly lower magnetic flux amplitudes could theoretically become biologically 
effective. For example, by increasing the frequency from 1 Hz to 1 kHz, the required peak 
magnetic field becomes approximately 0.1 T, which is more reasonable and technically is 
much easier and less expensive to achieve—but it remains very large. 
Slew rate 
As an alternative strategy to employing magnetic fields of very high amplitude it is 
both possible and sometimes advantageous to use high rates of change (steep slopes) coupled 
to otherwise low frequency pulses. It is in this use of the term frequency that confusion 
sometimes arises. For pure sine waves the meaning of the term frequency is defined as "the 
first time derivative of phase angle", whereas the meaning of the term frequency in reference 
to non-sinusoidal pulses is "how frequently the individual pulses are generated". Improper or 
imprecise use of the term frequency can lead to considerable confusion when defining the 
precise parameters for non-sinusoidal magnetic pulse waveforms. Trapezoidal and triangular 
magnetic pulses can be generated individually with long periods of inactivity between pulses, 
but it is possible by this approach to generate very large induced electric fields by driving the 
trapezoidal waveforms with very steep rising and falling edges, that is, incorporating large 
slew rates to each edge of each trapezoidal or triangular pulse. Such signals are easily 
capable of producing 1.5 V/m induced signals while keeping peak magnetic field strength 
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well below 0.1 T provided the pulse can be delivered in a short enough time (approximately 
100 µs). Frequency modulated signals provide an alternative method for producing high 
slew-rate signals by encoding low frequency signals in high frequency (1-27.12 MHz) 
sinusoidal carrier waves.  
The thermal noise threshold 
An interesting and important discussion must be had regarding the thermodynamic 
effects of electric fields. Specifically, as one decreases the magnitude of the induced electric 
field, there comes a point where thermal fluctuations due to random motion within the 
sample can easily produce field strengths large enough to mask the applied signal. This 
masking is referred to as the thermal noise threshold and is on the order of 9x10
-2
 V/m when 
signal averaging is not taken into account. Thus one would expect that any induced field 
below the thermal noise threshold should not induce a physiologic response. However, cells 
are able to integrate applied signals, which allows the theoretical noise threshold to fall even 
further to levels as low as 10
-3
 – 10-5 V/m69. Observations in literature support the claim that 
ICES efficacy can be observed orders of magnitude below the thermal noise threshold—a 
feat that is attributed to the ability of tissues to integrate and amplify very small signals. 
Review of past literature 
Bone studies 
The majority of the evolution of ICES therapy in the 20
th
 and 21
st
 century has been 
driven by the development of bone-growth stimulators. When Fukada and Yasuda discovered 
that bone is piezoelectric and subsequent studies implicated that bone remodeling could be 
driven by this property, it was only a matter of time before people began exploring the 
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possibility that applied electromagnetic fields could drive other biological processes. Thus, 
much of the pioneering work done by Bassett, et al. laid the foundation for subsequent work 
in other tissues.  
Cell studies 
Effects of ICES on cells have been studied extensively in those cells of bone or 
cartilage-derived lineage. In vitro studies on both primary and immortalized cells have been 
conducted, and there is evidence to suggest that each responds differently to ICES
72
. Cell 
studies done on osteoblast-like cells have mainly focused on the nitric oxide synthase (NOS) 
pathway of cells such as MC3T3-E1 cells
8,9
. Proliferation in several different cell types has 
been extensively studied and found to be increased in the presence of low-magnitude ICES 
on the order of 0.002 V/m
20,45,73–76
. In addition to modulating proliferation, ICES has been 
implicated in the up regulation of DNA synthesis, IGF-2 (osteosarcoma)
77,78
, FGF-2 
(endothelial cells)
74
 and BMP-2 mediated osteoblastic differentiation in human mesenchymal 
stem cells (HMSCs)
79
. In addition to the studies on bone, there have been questions as to the 
efficacy of ICES in nerve regeneration. In particular, a study conducted at NASA by 
Goodwin, McCarthy and Dennis showed that human neuronal cells could be modulated by 
time-varying electromagnetic fields (TVEMF). They found differences in cell morphology as 
well as proliferation rates in cells that were cultured in the presence of TVEMFs
71,80
. While 
cell culture studies are important to understanding biochemical and cell-level responses to 
ICES, they cannot provide the tissue and organism level responses that can be gleaned from 
in vivo, animal and human studies. 
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Soft tissue studies 
To understand the effects of ICES therapy on a system level, we feel it is easiest to 
break the existing literature into the broader categories of nerve healing, and anti-
inflammatory studies. Because ICES is so well established as an effective treatment in bone-
healing, we choose not to review that literature—however the reader should be aware that 
there is a vast literature concerning bone remodeling (A good reference with which to start is 
the 1974 Bassett reference).  
Nerve healing 
To understand the effects of ICES on nerve regeneration, we have broken the in vivo 
studies into three broad categories: peripheral, spinal cord and cortical studies. We have 
chosen to separate the cord from central and peripheral studies because it is the junction point 
for both central and peripheral nerves, and thus has the potential to affect both 
simultaneously. 
The focus of the majority of peripheral nerve studies has been to examine the ability 
of ICES to temper pain and stimulate regrowth. As previously mentioned, the studies 
performed at NASA by Goodwin et. al. indicated that neuronal proliferation could be 
significantly affected by low frequency pulses much lower in magnitude than the earth’s 
magnetic field. Studies performed by Raji et al. have shown that rat peroneal nerve 
regeneration can be enhanced by the use of ICES
43,44
. 
The majority of the published, controlled laboratory studies on peripheral nerves 
examine the effects of ICES on sciatic nerve lesions. Significant evidence from animal 
studies suggests that ICES is potentially effective in accelerating sciatic nerve healing. 
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Square wave pulses (~600 T/s magnetic flux rate), as studied by Sisken et al., seem effective 
in increasing sciatic nerve regeneration regardless of the orientation of the Helmholtz 
stimulation coils
47
. However, Baptista et. al. showed that there was no significant effect from 
treating sciatic crush lesions in Swiss mice using a stimulation protocol that induced a 20 
kT/s magnetic flux rate—a relatively large stimulus81. 
Finally, it is important to discuss the potential cortical effects of ICES. Cortical 
effects should be considered from two different views: direct stimulation (ex: rTMS, low 
magnitude ICES, etc.) which stimulate the brain directly, and indirect stimulation that causes 
cortical remapping or modulation through plasticity by stimulating peripherally. Direct 
stimulation methods such as those used in the studies published by Sandyk et al. have 
indicated that very small induced fields may be effective in alleviating some of the 
difficulties associated with multiple sclerosis and Parkinson’s disease29–40. However, it 
should be noted that the field strengths in question fall far below the thermal noise threshold 
and that the majority of these studies are case studies, not controlled laboratory studies. 
Unfortunately the literature regarding the central effects of peripherally applied ICES on 
central nerve function is rather sparse. Because peripheral neurons play a very large role via 
the feedback mechanism in cortical plasticity, it follows that if ICES affects these neural 
feedback loops, then fMRI and PET studies would reveal potentially significant effects of 
peripherally applied ICES on cortical plasticity. 
Inflammatory pathways 
In order to properly understand the potential mechanisms by which ICES may interact 
with the body, it is vital to explore the processes of inflammation. Inflammation typically 
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follows a well-defined series of steps that are mediated by specific molecules and cells in the 
body. Acute inflammation can be distinguished from chronic inflammation by molecular and 
cellular differences (however, the transition from acute to chronic is still poorly defined). 
The inflammatory process is initiated by a noxious stimulus—such as a burn, cut, 
blunt trauma, chemical exposure, auto-immune response, or infection. In all situations, the 
cascade begins when a pattern recognition receptor (PRR) on the surface of an immune cell 
detects the presence of a pathogen-associated molecular pattern (PAMP) or a damage-
associated molecular pattern (DAMP). Molecular patterns are molecules that are released in 
response to a noxious stimulus. Upon detection of a pattern, the PRRs trigger the release of 
various inflammatory factors which lead to increased blood flow, vascular permeability, and 
hyperalgesia—the inflammatory factors released depend upon the type of stimulus as well as 
the duration of the stimulus (i.e. acute vs. chronic). These inflammatory factors cause the 
classic signs of inflammation: Rubor (redness), calor (heat), tubor (edema/swelleing), dolor 
(pain), and function laesa (loss of function). 
Pattern recognition receptors are a family of receptors that are specifically tuned to 
respond to pathogens and damage-associated molecular patterns (PAMPs and DAMPs). A 
recent review highlights that there are four accepted PRR families: Toll-like receptors 
(TLRs), C-type lectin receptors (CLRs), Retinoic acid-inducible gene (RIG)-1-like receptors 
(RLRs), and NOD-like receptors (NLRs)
82
. These four families can be classified as 
belonging to either the transmembrane protein family or cytoplasmic protein family. 
Specifically, TLRs and CLRs are both families of transmembrane proteins, and RLRs and 
NLRs are cytoplasmic proteins. Most TLRs respond to bacteria, viruses, and protozoa; CLRs 
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typically respond to fungal infections; NLRs respond to bacteria, and RLRs respond to RNA 
and DNA viruses
82
. 
Pathogen and damage associated molecular patterns are the specific ligands that 
trigger a response in PRRs of the immune system. Lipopolysaccharides such as those found 
on bacteria, are examples of PAMPs that can trigger an immune response. Damage 
associated molecular patterns are groups of molecules that are released in response to 
physical damage to cells and tissues. It should be noted that PAMPs and DAMPs have 
become a more recent focus of study, and at this point, are relatively poorly understood. 
 
Figure 1.4: Chemical structure of λ-carrageenan. A representative chemical structure 
drawing of a single molecule in a polymer chain of the algal-derived sulfonated 
polysaccharide λ-carrageenan. A bolus of a 1% λ-carrageenan solution is given via 
injection to induce inflammation in the carrageenan-induced rodent footpad edema 
model of acute inflammation. 
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A very well-established model for the study of the anti-inflammatory efficacy of new 
drugs is the carrageenan-induced footpad edema (CFE) model
83,84
. This model makes use of 
an injection of λ-carrageenan (an algal-derived sulfonated poly-saccharide, Figure 1.4) into 
the footpad of a rodent (typically rat or mouse). The CFE model is an acute model of 
inflammation, and therefore typically resolves spontaneously within the course of 8-12 hours 
while displaying mostly acute inflammatory-associated cytokines and proteins. It has been 
shown that the CFE model displays two inflammatory responses: a non-phagocytic 
inflammatory response (NPIR) and a phagocytic inflammatory response (PIR). The NPIR 
occurs first, and is initiated by the trauma associated with a subcutaneous injection, and is 
dose-independent for carrageenan. The second, more prolonged, PIR occurs approximately 
60 minutes post-injection and involves recruitment of neturophils and macrophages
84
. 
Furthermore, it has been shown that pleural injection of carrageenan does not result in an 
NPIR, but rather a PIR only—thus implicating the damage associated with an injection into 
solid tissue as the cause for the NPIR
83
. To control for NPIR it is common to inject the 
contralateral (non-treatment) hind footpad with an equivalent volume of sterile PBS—this 
triggers NPIR but does not trigger a PIR, allowing one to subtract the swelling caused by 
NPIR from the CFE induced footpad. 
An important aspect of the CFE model is that it is strongly suppressed by the 
introduction of steroid anti-inflammatory agents such as dexamethasone. Dexamethasone 
inhibits production of arachadonic acid—a phospholipid derivative which is necessary for the 
production of leukotrienes, prostaglandins and thromboxanes. Figure 1.5 shows a 
representation of the arachadonic acid inflammatory pathway. A bifurcation in the use of 
arachadonic acid occurs which has downstream implications for inflammation. The 
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lipoxygenase pathway causes downstream production of leukotrienes which are heavily 
involved in neutrophil chemotaxis. The cyclooxygenase pathway produces prostaglandins 
and thromboxane as downstream products. Prostaglandins have many systemic effects, but 
are specifically associated with smooth muscle contraction modulation, platelet aggregation 
modifications, hyperalgesia and pyrogenesis. Prostaglandins have also been implicated in the 
modulation of neuronal sensitivity to pain. The end effects of prostaglandins are on average 
to increase blood flow (via vasodilation), reduce platelet aggregation, increase pain, and 
increase temperature. Thromboxane on the other hand has a tendency to increase platelet 
aggregation (and thus cause clotting), while also causing vasoconstriction which reduces 
blood flow. 
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Figure 1.5: Diagram of the arachadonic acid inflammatory pathways. A bifurcation in 
the pathway explains the differences between dexamethasone anti-inflammatory 
treatments and commonly available over the counter non-steroidal anti-inflammatories 
(NSAIDs). Dexamethasone-like drugs inhibit arachadonic acid formation, while 
NSAIDs inhibit the cyclooxygenase pathways. 
A final note should be added regarding two other important inflammatory pathways 
that are involved. First is the platelet activating factor pathway—a pathway which leads to a 
change in vascular permeability as well as contributing to leukocyte trapping. A second 
pathway is the nitric oxide pathway—which is responsible for changes in vasodilation. 
Specifically nitric oxide causes smooth muscle relaxation which leads to an increase in 
vasodilation. Because nitric oxide synthase pathways are activated in inflammatory 
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responses, swelling is (typically) increased as a result of edema caused by increased blood 
flow. The nitric oxide synthase pathway is a specific pathway of interest in the study of ICES 
as it has been implicated by several researchers as the primary mechanism by which ICES 
operates physiologically
6,7,10,18,19,67
.  
Anti-inflammatory effects of ICES 
There are two notable studies that shed significant mechanistic light on the anti-
inflammatory and pain reducing effects of ICES: those of Per Hedén et al. and Christine 
Rohde et al
10,11
. Both studies examined the post-operative effects of ICES on breast 
augmentation and breast reduction patients respectively. In the former, a pilot study of 
patients undergoing breast augmentation, ICES (2-ms bursts of 27.12 MHz PRF, 3.2 V/m 
peak applied for 30 minutes every 4, 8 or 12 hours on different post-operative days) was 
shown to significantly reduce pain scores
11
. The second study, performed by Rohde et al. 
using similar ICES parameters showed significant pain reduction, and interestingly a drastic 
reduction in IL1-β levels in wound exudate as compared to sham groups10. Reduction in 
inflammatory factors suggests at least one possible biochemical mechanism—perhaps the 
Ca
2+
/CaM dependent NOS pathway suggested by Pilla et al
7
. It is interesting to note that 
although these reports and others have demonstrated very significant and repeatable 
reduction in post-operative pain when ICES is correctly applied without evidence of adverse 
side effects, while the use of narcotics to manage pain has severe and well documented health 
and social effects, there does not appear to be any increase in the clinical acceptance of ICES 
stimulation for the management pain. Essentially—despite growing support in the peer-
reviewed literature, the availability of many commercial ICES products, and the lack of 
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evidence indicating adverse effects—the use of ICES for any form of pain management 
remains outside even the fringe of standard medical practice. 
Possible mechanisms of inflammation reduction  
While there are many possible mechanisms by which ICES could influence cells, 
tissues, organs and whole systems—there only a few basic mechanisms that are adequately 
explored in the scientific literature. 
For low-amplitude magnetic fields, a Larmor precession model is discussed which 
states that the Larmor precession behaviour of certain atoms or molecules (such as water) can 
be modulated in the presence of a magnetic field. In the case of water, modifying the Larmor 
precession can impact the ability of thermal fluctuations to drive chemical reactions—
shifting the amount of energy required by a ligand to displace water from a binding site on a 
target molecule
5,17,85
. 
 Next is an implicit theory which is not always discussed explicitly: Eddy current 
interactions with signaling proteins. The fundamental idea of this first theory is based on 
Faraday’s law of induction which states that electromagnetic eddy currents can be induced in 
a conducting surface (such as a slice of tissue) by a time-varying magnetic field. In the 
presence of a changing magnetic field, the electrolyte surrounding cells can act as a 
conducing medium and eddy currents can flow in these spaces. If there are free ions in 
solution, presumably they could be placed into organized motion and their frequency of 
interaction with their receptors of interest might be preferentially increased or decreased, 
causing a cell response. Another possibility is that proteins are affected directly—since every 
biochemical reaction is driven fundamentally by the electromagnetic force, it follows that 
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protein binding pockets could be modulated by induced EMFs or eddy current flow. A more 
specific proposed mechanism is that put forth by Pilla and his collaborators, which states that 
ICES of the appropriate waveform and pulse duration (specifically pulsed radio frequencies) 
is able to modulate the Michaelis-Menten binding kinetics of the Calcium-Calmodulin 
dependent nitric oxide synthases. The theory that ICES functions via modifying Ca/CaM 
binding has been supported in the literature for cell-free preparations, as well as in vitro and 
in vivo studies
2,5,7,10–13,18,19,68,86
. Modulating such a fundamental pathway could result in 
modulated levels of NO production and therefore have very drastic downstream effects in the 
body.  
 Another consideration to be made is that electrical stimuli are known to have well-
understood effects on muscle, bone and nerve tissues. Muscles, bones and nerves all require 
electrical stimuli on various scales of time and signal intensity from millisecond time base 
curing events of excitation and action potential generation, to much lower levels signals that 
are hypothesized to be essential to the maintenance of homeostasis and functional 
adaptation—thus it is not a far stretch to suppose that ICES acts to promote homeostasis or 
facilitate functional adaptive responses in cells/tissues that have been injured. Because the 
ICES protocols used in the following experiments are based on stimulation patterns found in 
healthy, adult-phenotype muscles and nerves, it may be that part or all of the effects seen for 
ICES are a result of an electrically-mediated restoring force towards physiological 
homeostasis. Tissues have evolved such that they respond to specific stimulation patterns and 
selectively ignore all other stimuli which are not relevant. Evidence of the previous claim can 
be found in the fact that tissues are essentially transparent to static magnetic fields, and the 
majority of electromagnetic phenomenon that are either in the ambient background or those 
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that are man-made. Thus, it is very reasonable to assume that appropriately chosen 
stimulation patterns should be interpreted by electrically responsive tissues as homeostatic in 
nature and could thus promote a reduction in inflammation (i.e. promote a lack of change 
from homeostasis). 
A different viewpoint is that cells can be modeled as living finite state machines.  
Cells could find themselves locked into perpetual pathologic states even after the 
insult/injury has long passed.  Thresholds for transition from state-to-state may change with 
age of the organism in question.  This is one explanation for why exercise response changes 
with age: the threshold for promoting a transition from homeostasis to tissue repair or 
functional adaptation to exercise may change with age along with the threshold for 
pathologic chronic response to injury, such that under certain circumstances, such as 
advanced age, it becomes easier to induce a state of chronic pathological response while it 
becomes more difficult to elicit the desired adaptive response from the cells/tissues.  It is 
possible that ICES with appropriate stimulation parameters reinforces the transition to the 
positive adaptive state while reducing the response to a change to the undesirable chronic 
pathologic state.  And crucially, if ICES facilitates adaptive signaling that emulates the so-
called “exercise response” without the need for physical stimuli such as exercise, the 
beneficial effects may be enhanced simply because the exercise response can be elicited 
without the risk of actual physical injury. Such a mechanism might allow bedridden patients 
to heal without overexerting their capabilities. Furthermore, ICES might also be used to help 
prevent bone and muscle atrophy in astronauts and individuals under conditions wherein they 
do not receive the necessary physical stimulation to maintain bone density and muscle mass. 
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Central and peripheral nervous system components should be considered as well. Pain 
is perceived through signals transmitted from the peripheral nervous system to the central 
nervous system. To some extent, pain transduction is poorly understood, but generally 
speaking, pain is detected by free nerve endings which sense changes in heat, pressure and 
chemicals. When inflammation occurs, local pressure gradients are changed, resulting in 
physical forces on nerves (pressure) which can cause irritation and pain. Furthermore, tissue 
damage releases cytosolic components that are known to irritate nerves and cause pain. 
Long-term activation of inflammatory pathways is known to lead to cortical remapping and 
chronic pain
87,88
. 
These theories are far from complete or comprehensive; however, they serve as a 
good beginning to the development of an understanding of the basic mechanisms to elucidate 
the effects of ICES on the body. 
Possible mechanisms of pain reduction 
In order to understand the possible mechanisms by which ICES might modify pain in 
the body, it is important to understand the central and peripheral organization of pain. 
Peripherally, pain is typically described in terms of the nerve types that carry the pain data. 
There are two classic peripheral pain pathways in the body: “Slow” pain, conducted by 
unmyelinated C-fibers; and “fast” pain, conducted by myelinated Aδ fibers.  
Slow pain—typically described as visceral, deep, achy, nauseous pain—is conducted 
peripherally through C-fibers that carry information at a rate of 0.5-3m/s. The unmyelinated 
nerve endings synapse in the spinal cord within laminae layers II and III (collectively known 
as the substantia gelatinosa) of the dorsal horns. From the substantia gelatinosa, the signal is 
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carried to layer V, where it then travels up the paleospinothalamic pathway to the brain. In 
the brain, slow-fiber pain neurons terminate in the thalamus, reticular nuclei, tectal area and 
periaqueductal gray regions prior to transmission for higher-level processing in the 
somatosensory cortex (3a)
87
. 
Fast pain—typically described as shallow, sharp and well localized—is conducted 
peripherally through Aδ fibers that carry information at a rate of 2-30 m/s. From the 
periphery, primary Aδ fibers travel to the spinal cord where most synapse with secondary 
nerves in Lamina I of the dorsal horn. From Lamina I, the secondary nerves cross to the 
contralateral side in the anterior commissure prior to traveling superiorly through the 
neospinothalamic pathway to the thalamus. From the thalamus, the pain signal travels to SI 
area 1/3b for processing.  
The central nervous system also has the ability to modulate the pain response 
peripherally through analgesic pathways. These pathways tend to originate from the 
periaqueductal grey matter as well as the periventricular nuclei. Stimulation of these nerves 
provides enkephalin-based signaling to the Raphe Magnus, where they synapse with 
secondary seritonergic neurons that travel through the dorsal lateral funiculus, making 
connections with enkephalin neurons that project to the dorsal horn and provide inhibitory 
connections to laminae I, II, and V. Additionally, there are projections from the medulla and 
pons that provide additional inhibition by projecting to laminae I and V
89
. These feedback 
mechanisms are known to project from the central nervous system because stimulation of the 
periaqueductal grey matter has a strong analgesic effect while also blocking spinal-cord 
reflex responses to painful stimuli. 
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Additionally, it should be noted that neurons in laminae I and V likely receive 
afferent input from non-nociceptive Aβ fibers. It has been shown that Aβ fibers projecting to 
lamina V have inhibitory effects on nociception by stimulating inhibitory neurons that project 
to lamina II. This inhibition tends to inhibit nociception. However, it should be noted that 
nociceptive inputs from Aδ and C fibers also have effects on the inhibitory interneurons in 
lamina II
89—which is to say that Aδ and C fibers feed back on Aβ fibers and vice versa. 
Simply put, nociception can be inhibited by non-nociceptive (typically mechanical) 
stimulation, and mechanical perception can be inhibited by nociception. 
Finally it is worth noting that there are various central pathways via which opiates 
and other chemical analgesics can affect pain, however since this discussion is mostly 
concerned with how ICES might interact with pain perception, we choose to simply mention 
that these pathways can be stimulated electrically and chemically, as well as inhibited by 
drugs such as Naloxone. Stress response in humans is a known factor that can cause 
activation of the opiate pain reduction pathways. 
The general organization of pain typically regards the thalamus as the primary region 
through which the pain signal is relayed prior to higher-order processing in the 
somatosensory cortex. As mentioned previously, Aδ and C fibers are currently understood to 
project to areas in S1 of the post central gyrus (Brodmann areas 1, 2 and 3). Specifically, Aδ 
fibers are hypothesized to project to areas 1 and 3b, while C fibers are hypothesized to 
project to area 3a. The general interaction between central processing of peripheral inputs 
from Aδ, Aβ and C fibers is shown in Figure 1.6. 
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Figure 1.6: Simplified illustration of central interactions between Aδ, Aβ and C fibers. 
(Top left/blue) Activation of Aδ fibers increases activation in area 3b/1 of SI, while at 
the same time inhibiting input from peripheral Aβ fibers and inhibiting central area 3a. 
(Bottom left/yellow) Activation of non-nociceptive Aβ fibers inhibits peripheral Aδ and 
C fiber signals, while upregulating area 3b/1 and inhibiting area 3a of SI. (Bottom 
right/red) Activation of peripheral C fibers inhibits peripheral Aβ (non-nociceptive) 
input, while centrally activating area 3a and eventually inhibiting 3b/1 of SI. 
Briefly, in the presence of afferent nociceptive input from Aδ fibers, Aβ input is 
inhibited in the spinal cord in lamina II by inhibitory interneurons. Aδ input is processed in 
area 3b/1, thus activation of this area is caused upon sharp nociception—simultaneously, 3a 
is inhibited
87. If Aβ fibers are activated peripherally, they cause a corresponding inhibition of 
both Aδ and C fiber input from the periphery by activating inhibitory interneurons in lamina 
II that project from lamina V. Aβ fibers project to area 3b/1 in SI, and tend to have a net 
inhibitory effect on area 3a
87. Finally, C fibers inhibit Aβ afferents while stimulating area 3a 
and inhibiting 3b/1 in SI. The implications for the aforementioned pathways are that: 
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1. Mechanical stimulus carried by Aβ fibers can modulate the perception of pain both 
centrally and peripherally. 
2. Nociceptive stimuli carried by C fibers can modulate the perception of mechanical 
stimulus centrally and peripherally. C fiber stimulus only modulates perception of Aδ 
fiber input centrally by inhibiting area 3b/1 in SI. 
3. Nociceptive stimuli carried by Aδ fibers can modulate the perception of mechanical 
stimuli centrally and peripherally; however Aδ activation only modulates nociception 
from C fibers centrally by activating area 3b/1 and inhibiting 3a. 
 In order to appropriately address the question of how external electromagnetic stimuli 
might modulate pain response, it is essential to ask the question: How is pain transduced? It 
is very well established that both C and Aδ fibers are free nerve endings (i.e. they do not 
specifically “connect” to anything like a Pacinian corpuscle, etc.). Furthermore, it is still 
debated as to the exact mechanism by which nociceptors can distinguish between the 
different types of pain, degrees of pain and qualities pain. It is well understood that C fibers 
are typically responsible for transmission of heat information, but they are also responsible 
for other types of slow pain such as aches, nausea and deep, poorly localized pain. Similarly, 
Aδ fibers have a similar problem: they seem to be able to describe several types of pain, yet 
they are all essentially identical. Recently, it has been proposed that one of the ways in which 
pain is transduced is by modifying the conditions in the cells surrounding the free nerve 
endings in question
90
. Specifically, it is hypothesized that levels of nucleotides (specifically 
ATP) can significantly affect the ability of nerves to respond to stimuli
90
. Specific receptors 
(such as TRPV1, as well as the P2X and P2Y families) are implicated directly in the 
transduction of signals by nerve endings. The P2 families of receptors in particular are 
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sensitive to extracellular ATP levels—allowing them to be capable of modulating nerve 
response. In addition to having nucleotide receptors that modulate nociceptive quality, it 
should be noted that all nociceptive stimuli are likely to elicit responses in surrounding non-
nociceptive somatosensory afferents. Thus, when integrated in the CNS, perception of the 
quality of pain is likely the result of both nociceptive and non-nociceptive somatosensory 
input. 
 From a cellular standpoint, there are a plethora of factors involved in determining the 
ability of a nerve to send signals. In our case we are specifically interested in those factors 
that can be modulated peripherally. Perhaps the most obvious factor influencing neural 
activity is resting membrane potential. The resting membrane potential is developed by the 
presence of ion channels that provide an equilibrium state between [mostly] sodium (Na
+
), 
potassium (K
+
), and chloride (Cl
-
) ions. The permeability of these and other channels (such 
as Ca
2+
) is modulated at the time of activation to allow for an inversion (depolarization) of 
the membrane potential. Various mechanisms are involved in re-developing the membrane 
potential (repolarization) so that the nerve is reset after depolarization. Modulation of any of 
these three states can give rise to a different type of signal. The activity of neurons under 
normal conditions can be modulated in several ways: 1) Driving the membrane potential 
exogenously (e.g. direct electrical stimulation), 2) by input from other nerves (stimulatory or 
inhibitory), 3) by availability of electrolytes and signaling molecules, 4) by the ability of ions 
and neurotransmitters to interact with their respective target (e.g. the ability of Na
+
 to flow 
through a channel, or the ability for NMDA to bind its receptor, etc.), and 5) by modifying 
the surrounding tissues which release modulating factors into the pericellular space. Each of 
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these modulating factors is a potential target of ICES, however only two of these four are 
likely, as discussed below. 
One of the most obvious methods by which one might expect to be able to modulate 
the membrane potentials would be to directly drive the membrane potential electrically. This 
is the putative mechanism of primary signal transduction in the case of transcutaneous 
electrical nerve stimulation (TENS) and other direct electrical stimulation methods. The 
problem with direct electrical stimulation is that uneven stimulation occurs at a microscopic 
level within tissue. Local overstimulation occurs along electrically conducting pathways, and 
local under-stimulation occurs along pathways that do not carry current—thus there is both a 
risk of damage to cells from over-stimulation and simultaneous under-stimulation of cells 
outside of the conductive pathway. Inductive methods such as ICES result in a more uniform 
method of delivering electrical stimulus, as magnetic field lines are left relatively unaltered 
by transmission through tissues. Pulsed magnetic fields are able to develop circular eddy 
currents in a conducting plane proportional to the rate of change of the magnetic flux (or 
simply the field strength in the case where the stimulated area is not changing). In the case of 
transcranial magnetic stimulation (TMS), induced field strengths on the order of 0.03-0.15 
V/m have been shown to have significant interactions with the CNS
91
. Across the width of a 
cell body, one might expect then that potentials on the order of 0.3 µV could potentially 
affect neural function. ICES typically uses smaller magnetic field strengths than rTMS, but 
because it is capable of providing rapidly changing, low-magnitude magnetic fields, it is 
capable of inducing potentials on the order of 1-10 V/m around a cell diameter. Thus, while 
the magnitude of these ICES fields would not likely be large enough to elicit a depolarization 
in most cells, it is probable that they could produce a potential of 0.1 mV across a cell 
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body—leading to a modulation in the sensitivity of the neuron to firing. However, since a 
change of 0.1 mV is only about 0.1% change in the potential across the cell, it is unlikely that 
such a minute change would act directly on driving the membrane potential. Also note, the 
induced eddy currents would induce electrical potentials and ion flux transverse or parallel to 
the non-conducting membranes rather than across them, as membrane potential is defined. It 
is more likely that a small change in membrane potential would lead to a modulation in the 
permeability of membrane proteins responsible for developing the standing membrane 
potential. It is worth noting that one might expect a difference in the effects of ICES on cells 
based on whether or not they are myelinated. Since myelin is an insulator, it can act like a 
capacitor, thus an electric field developed across the myelin sheath could in fact cause 
longer-lasting effects that those on a non-myelinated sheath. Additionally, myelin may shield 
the nerve from some of the electrical signal, reducing the efficacy of ICES on heavily 
myelinated neurons. Finally, un-myelinated nerves are exposed directly to electric fields 
produced by ICES, as a result, they may be more strongly stimulated—however more likely 
in a more transient manner than myelinated cells. One reason to explain the lack of transience 
in a myelinated cell might be that because myelin is a dielectric, it can store energy in the 
form of an induced electric field (in precisely the same way as a capacitor dielectric stores an 
electric field). When an external stimulus is removed, there is a time-constant associated with 
the breakdown/relaxation of the internal dielectric field
92–94
. Thus, prior to the complete 
relaxation of the dielectric myelin there can be transient induced fields that may very well 
cause extended effects of ICES on myelinated nerves. It should be noted, that these are 
simply conjectures. Experiments will be discussed later that might offer some insight for 
differentiating potential mechanisms. 
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A slightly less obvious mechanism by which ICES may interact with cells (including 
neurons) is by modifying the ability of target ions to bind their appropriate receptor. There is 
a large amount of literature to suggest that calcium is one ion that can be easily modulated by 
ICES
1,2,4,7,10,11,17–19,67,68,86,95
. Specifically, calcium in the context of calmodulin activation has 
been studied—however the specific model developed by Markov and Pilla that predicts the 
interactions of calcium with its target calmodulin can be developed for nearly any ion and 
receptor in the body. Above a certain threshold stimulation intensity, the relevant parameters 
for modifying binding are frequency and pulse width
7
. Modifying the ability of ions to 
interact with their targets has obvious implications for both resting membrane potential as 
well as sensitivity to depolarization.  
Modifying the availability of ions and neurotransmitters is unlikely to be a 
mechanism by which ICES interacts with neurons—with the exception of perhaps modifying 
the availability of neurotransmitters produced by other cells (such as nucleotides, etc. 
produced in non-nerve cells). 
Modifying inputs from other nerves would likely be an indirect feedback mechanism 
caused by a direct interaction of ICES with a peripheral nerve. For example, if ICES 
modulates the activity of a peripheral neuron that projects to an area of the CNS that provides 
a feedback response to peripheral nociceptive neurons (such as the central feedback 
mechanisms described above), then pain could be amplified or inhibited by the interactions 
of ICES with peripheral nerves.  
Neural firing is contingent upon signals received from surrounding cells. If ICES 
interacts with cells as described by Pilla et al.
7
, then it follows that metabolic activity of cells 
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surrounding neurons should be modulated by ICES. Furthermore, if there are pericellular 
current flows within innervated tissues, one would expect a corresponding change in tissue 
metabolism
1
. Thus, if one modifies the conditions of the surrounding tissue using ICES, a 
neuron might be expected to behave differently given the same stimulus. This also implies 
that if nociception is typically proportional to tissue damage, that if inflammation is reduced 
by ICES, then the intensity of nociception should decrease
10,11
. 
Possible cutaneous wound healing mechanisms 
ICES has been implicated in wound healing in the literature, and may hold the 
potential to modify scar formation pathways. Scar formation is typically governed by a well 
understood mechanism involving fibroblasts laying down a well-organize collagen matrix. 
There are three well understood types of scarring—hypertrophic, keloid and atrophic. The 
typical scar is formed in the following steps: 
1. A wound is created (cut, scratch, surgery, lesion, etc.) 
2. Inflammatory mechanisms are activated (inflammatory factors released, vasodilation, 
increased blood flow, macrophage response, immune response, etc.) 
3. Repair mechanisms are triggered to form a scar (fibroblasts and other repair cells start 
laying down new matrix) 
Upon tissue damage, several events trigger fibroblast migration and differentiation. 
Chemical factors are released into the tissue surrounding the wound—cytokines from 
damaged cells trigger inflammatory and healing factors to be recruited to the site of damage. 
Additionally, because the existing extracellular matrix and connective tissue surrounding a 
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wound is disrupted, the mechanical stimuli to which the cells are accustomed in homeostasis 
change. Evidence has been collected to demonstrate that fibroblasts normally experience very 
little average extracellular mechanical stress due to the amount of crosslinking in the 
extracellular matrix in which they exist. In the presence of a wound (i.e. a source of high 
extracellular stress), fibroblasts are then hypothesized to undergo differentiation into 
myofibroblasts—a subset of fibroblasts that express α-smooth muscle actin (α-SMA)96–102. 
This mechano-differentiation hypothesis is supported by the fact that stress fibers readily 
form in vitro when fibroblasts are plated on hard-substrates (such as polystyrene), but do not 
form when grown in soft hydrogels such as collagen
97
. Once fibroblasts have moved into a 
wound, they begin expressing stress fibers in the form of cytoplasmic actins—this phase is 
called the “protomyofibroblast” stage102. These stress fibers connect to both integrins of cell-
matrix junctions as well as N-cadheren-type adherens junctions
102
. In vivo, these stress fibers 
are eventually replaced with α-SMA when the pseudomyofibroblasts are exposed to TGF-β1. 
As well as from the circulating fluids in a wound, TGF-β1 is released by the existing and 
newly formed ECM when the psudomyofibroblasts begin supplying a mechanical stress to 
the ECM
103
. A wound can then be pulled closed by the stronger pull of α-SMA before scar 
formation begins as myofibroblasts begin laying down thick extracellular matrix. 
Pulsed electromagnetic fields have also been conjectured to accelerate wound 
healing. There are several mechanisms by which one might expect PEMFs to accelerate 
wound healing. The first mechanism is that appropriate waveform parameters may induce 
microcurrents to flow in and around pericellular spaces
1
. Such stimulation would obviously 
have repercussions in terms of modulating ion flow, activating extracellular proteins—this 
mechanism would most likely affect metabolic rate, as well as anti-inflammatory factor 
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expression. A second mechanism is that put forth by Arthur Pilla et. al. and suggests that 
ICES can modulate the rate at which calcium binds to calmodulin, thus increasing the rate at 
which eNOS and nNOS can produce nitric oxide intracellularly. Such a mechanism is 
proposed to directly reduce levels of interleukins as well as other inflammatory factors
6–
8,10,11,18,19,68
. A reduction in said inflammatory factors could rapidly increase the rate at which 
a wound can heal. It should be noted that both of these mechanisms could lead to pain 
reduction by reducing inflammation. A third possible mechanism (or at least contributing 
factor) is that ICES stimulation may electrically modulate epithelial secretion of neuroactive 
agents. Specifically it is hypothesized that nucleotide signaling is critical to nerve 
sensitization, and that an increase in ATP is likely to increase the ability of peripheral nerves 
to transduce pain signals to the central nervous system
90
. In conjunction with the previous 
observation, it is important to consider the nervous system globally—any electrical stimulus 
is likely to have effects on resting membrane potential—resulting in hyperpolarization or 
depolarization. There are obvious impacts of modulating nervous system peripheral signals—
the least of which is that modulation of signal transduction can affect the way the pain is 
perceived centrally. A reduction in pain reduces circulating stress molecules which can 
further lead to a reduction in inflammation—accelerating wound healing. Globally, however, 
the generally accepted mechanism by which ICES interacts with cells is based upon ion-
interactions with different membrane bound and non-membrane bound enzymes. 
Summary and the future of ICES 
The ICES literature is rather sparse when one considers the vast continuum of 
electromagnetic frequencies and amplitudes. The problem of organizing and classifying 
effective ICES waveforms in tissues is similar to the problem faced by Mendeleev and other 
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chemists who faced the growing problem of classifying elements into the periodic table. 
More recently a similar problem was faced by subatomic particle physicists such as Glashow, 
Weinberg and Salam in trying to develop what we now call the Standard Model—a method 
for classifying and understanding the subatomic particles and their interactions. The problem 
faced by these influential scientists is not completely held in simply organizing 
information—it was in taking a large amount of completely unorganized information and 
convincing a scientific community of an effective means of organizing the information. The 
importance of such organization is twofold. First, organization helps to circumvent vicious 
arguments between those seeking answers to the same problems by giving objective grounds 
on which to make rational arguments. And secondly, possibly more importantly, it allows 
outside viewers—those not directly involved in the scientific community—the opportunity to 
understand clearly the methods and goals of the study. If organization at this level can be 
achieved, then the ICES community as a whole can make research progress at an incredible 
pace. As a research community it is important to apply several simple principles in 
experiments and articles that will help to alleviate the questions that are often generated by 
those not directly involved in the research. First, it is important to strive to be scientifically 
rigorous—any published experiment MUST include adequate information to completely 
replicate the experiment. Waveform parameters must be fully and carefully defined such that 
an induced electric field can be calculated. In some cases the parameters should be measured 
and determined experimentally, using well-calibrated instruments suitable to the task. 
Secondly, it is important that authors choose effective and specific titles for articles. Titles 
such as “PEMF is Not an Effective Means of Treating Rotator Cuff Injury” do not help the 
already confused literature (unless every single frequency, amplitude, waveform structure 
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and treatment regimen was tested). Consider the possible title for a study in which the drug 
aspirin (acetylsalicylic acid) was found to be ineffective in reducing post-operative pain. The 
resulting manuscript titled "Drugs are not effective in the treatment of post-operative pain" is 
non-specific to the point of being both misleading and incorrect. Just as there are many types 
of drugs, there are vast numbers of different ICES stimulation protocols. The lead advisor for 
this dissertation (Dennis) estimates the number of potential ICES stimulation protocols to be 
on the order of 10 trillion (unpublished estimate). Therefore, titles should include at 
minimum a descriptor of the magnetic field waveform such as “75 Hz, 250 mH Sinusoidal 
PEMF is Not an Effective Means of Treating Rotator Cuff Injury.” This title allows those in 
the field to quickly isolate articles based on their treatment parameters, and it gives those 
outside the field an understanding that different ICES protocols are used for different 
reasons. Just as ultrasound has different clinically effective waveforms for different 
applications (imaging, targeted ablation, ARFI, etc.), both clinical practitioners and the 
educated public must understand that the same is likely true of ICES. Secondly, it is 
important that, as the ICES literature progresses and waveforms are grouped based on 
efficacy, we use consistent terms to define ICES stimulation protocol parameters (Table 1-1). 
Until a well-defined set of terms is established, understanding and forward progress in the 
use of ICES will be limited. Specifically, terms such as those found in Table 1-1 should be 
used to define a protocol in conjunction with the relevant magnetic slew rate. The most 
appropriate method for dosing ICES is by providing the magnetic slew rate and the pulse 
characteristics such that the power and/or length of time during which tissue is exposed to 
ICES may be calculated. An example dose might be 5 pulses per second (pps), 100 μs pulse-
length, at 80 T/s. Such a dosing allows one to calculate that an equivalent dose of 500 μs of 
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80 T/s stimulation is provided. It is, however, not correct to infer that such a dose is 
equivalent to applying a static 0.04 T field for any length of time. If the scientific community 
is strict with definitions, clear in its methods, and scientifically approaches the many 
questions posed by the interactions of ICES with tissues, then it can take the field from being 
in a questionable and disorganized state toward a respected and organized body of 
knowledge that has earned the respect of scholars and physicians. 
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CHAPTER 2 : IN VITRO STUDIES 
Overview 
 Herein we sought to examine the effects of inductively coupled electromagnetic 
stimulation (ICES) of specific parameters on the osteoblast-like MC3T3-E1 cell line. 
Previous research has indicated that ICES stimulation with the correct waveform 
characteristics can elicit a response from the calcium/calmodulin (Ca/CaM) mediated nitric 
oxide synthase (NOS) pathway
7–9
. ICES stimulation (80 T/s) was provided to MC3T3-E1 
cells plated in 6-well plates using a custom apparatus. L-N-monomethyl arginine was used as 
a NOS inhibitor and negative control to test whether NOS is a pathway stimulated by ICES. 
No significant changes in NOS levels were measured between any of the treatment groups at 
any point during the experiment. All NOS levels were below detection limits, which calls 
into question previously reported data indicating that NOS activity can be modulated in 
MC3T3-E1 cells using ICES. Further research should be conducted to examine which 
pathways are modulated by ICES. It is possible that different types of ICES modulate 
different inflammatory pathways. 
Introduction 
 Electromagnetic field therapy has been implicated as a healing agent for many years. 
While ancients document the use of presumed ferromagnets as an analgesic and healing 
agent, the efficacy of such treatments has been questioned for many years. More recently, 
other forms of electromagnetic therapy have been introduced as potential therapeutics for 
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various ailments—however the question as to the mechanism eluded scientists until the 
1950’s when pioneering work was done by Fukada and Yasuda in the subject of 
orthopaedics
23,24
. Fukada and Yasuda hypothesized and discovered that bones are 
piezoelectric in nature—furthermore, it was shown that bone degradation and augmentation 
occurred on the electropositive (anodic) and electronegative (cathodic) sides of an implanted 
electrode respectively
85
. The discovery that the piezoelectric properties of bone are directly 
linked to its augmentation and degradation led to the notion that bone healing could be 
accelerated using externally applied electric fields. Pioneering work by Bassett et. al. showed 
that healing of non-union fractures could be elicited and accelerated using externally applied 
electric fields
12–14. In the mid 1970’s, while the application of electric fields to bone 
regeneration were being studied, the notion that other tissues could be stimulated using 
externally applied electric fields came to light. Both capacitively and inductively coupled 
methods were explored and found to elicit cellular responses. It was also noted that non-
piezoelectric tissues were responding to electrical stimulation. While the notion that 
externally applied electric fields can elicit responses is rather easy to conceptualize 
considering the large proportion of aqueous ions in the body, the exact transduction 
mechanism was unknown. In 1974, Arthur Pilla proposed a mathematical description of the 
interaction between tissues and electric fields based on the modulation of ion-
dependent/triggered signal transduction pathways
2
. In particular, Arthur Pilla expanded on 
his work by studying the Calcium-Calmodulin (Ca/CaM) interaction in cells. Since calcium 
in the body exists as an ion (Ca
2+
), one might expect that it might be influenced to migrate in 
the presence of an electric field. Thus, Arthur Pilla built a mathematical model that examined 
the possibility of using capacitively and inductively coupled methods for stimulating 
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Ca/CaM binding in cells. Based on Michaelis-Menten style binding kinetics, Pilla proposed 
that ICES could be used to stimulate the Ca/CaM mediated nitric oxide (NO) anti-
inflammatory pathway under the appropriate waveform conditions. Specifically, Pilla found 
that only particular frequencies, pulse lengths and amplitudes actually elicit a cellular 
response
7,12,13,18,19,21
. Our conjecture is that the most important stimulation parameter in ICES 
is the rate of change of the magnetic flux. Our hypothesis is that higher rates of magnetic flux 
have the capacity to induce larger electromotive forces and therefore provide physiologically 
relevant signals to tissues. Herein we seek to replicate previously performed research in the 
field, while exploring the possibility that our ICES protocol acts via an established 
mechanism. 
Materials and Methods  
Cell culture 
 Osteoblast-like MC3T3-E1 cells (Passage 31) were obtained from the University of 
North Carolina at Chapel Hill Tissue Culture Facility (UNC TCF) in the Lineberger Cancer 
Research Center and stored over liquid nitrogen until use. Cells were grown in phenol-red-
free α-MEM (Invitrogen/GIBCO, Carlsbad, CA,SKU 41061-029) obtained from the UNC 
TCF, supplemented with 10% FBS (Cellgro, Manassas, VA), 100 IU/mL penicillin, 100 
µg/mL streptomycin (Cellgro, Manassas, VA), and 50 µg/mL ascorbic acid (Fisher 
Scientific, Pittsburg, PA). Some groups also received a 300 µM dose of N-monomethyl-L-
arginine (L-NMMA) as an inhibitor of NOS (Acros Organics, Geel, Belgium). Cells were 
grown in 15-cm petri dishes until approximately 80% of the surface was covered, then the 
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cells were split into 10, 10-cm petri dishes prior to being distributed into 6-well plates at a 
concentration of 78 cells/mm
2 
(5x10
5
 cells/mL). 
 Cells from the same passage (passage 32) were used in both the controls and the 
treatment groups to ensure no differences were as a result of passaging the cells. 
Furthermore, each 6-well plate contained both treatment and sham groups. Active coils 
(treatment group) were arranged in the configuration shown in Figure 2.1. Note that the 
inactive coil centers are approximately 40 mm from the treatment groups, and thus are not 
affected by the ICES fields. However, as a control, one set of 6-well plates had all active 
coils and another had completely inactive coils. Temperature was monitored using an 
infrared camera (FLIR Systems Inc., Sweden) so as to ensure that no inductive 
thermocouple/thermometer heating occurred. 
ICES stimulation protocol 
 Cells plated in 6-well plates were placed into custom-designed tray that allowed 6 
pairs (12 total) of coils (28 AWG, 80 turns, 35 mm average diameter) to be positioned 
concentrically above and below each of the 6 wells of the plate (Figure 2.1). Coils were 
energized to deliver 80 T/s stimulation through a custom built circuit as outlined in Figure 
2.2. All electronics were housed outside of incubators, and ribbon cables were used to 
connect the stimulation coils to the pulse generating electronics. 
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Figure 2.1: Diagram showing the in vitro 6-well ICES stimulator (Left) 3-D model of 
the ICES 6-well plate stimulator. (Right) Photograph of the assembled ICES stimulator 
with individual driving circuits able to provide various amplitude doses. Stimulation 
parameters are shown in Figure 2.2. 
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Figure 2.2: Representative drawing of the ICES stimulation protocols used throughout 
the experiments presented herein. The first stimulation protocol is alternating positive 
and negative pulses every 200 ms. The second and third protocols consist of five rapid 
pulses in succession followed by a 1-second period of rest. Amplitude dictates the final 
dosing (40, 80, 120 or 160 T/s). 
Cell count and viability assay 
 In order to assess the general growth and health of the cells used, cell counts and 
viability assays were conducted on the final day of culture (Day 15). Trypan blue was used to 
assess cell viability. Briefly, cells were trypsinized (0.05% trypsin-EDTA, Gibco 25300) and 
resuspended in 10 mL of growth medium, centrifuged in 50-mL conical tubes for 5 minutes 
at 100xg. Cells were then resuspended in 1 mL of PBS, and mixed with an equal part of 0.4% 
trypan blue dye. Cells were then counted after 3 minutes of incubation using a 
hemacytometer. 
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Nitric oxide assay 
 Since the proposed pathway of interest is the Ca/CaM mediated NO pathway, we 
found it pertinent to asses, indirectly, the amount of NO produced by the cultured cells. In 
order to further probe the claim that NO production is via the NOS pathway, we divided the 
treatment groups in two. One treatment group received a 300-µM dose of L-N-monomethy-
L-arginine (L-NMMA), a selective NOS inhibitor, while the other did not. Since NO is an 
unstable free radical, the most accessible method available to measure the NO concentration 
in the cultured cells was by measuring the indirect byproduct of NO metabolism , nitrite. 
Nitrite levels were assessed using the Griess reaction (Griess paper reference) each time that 
the cells were fed (Day 0, 2, 4, 7, and 9). The Griess reagents were provided by Promega kit 
G2930 (Promega , Madison, WI). Breifly, conditioned media was harvested and 50 μL from 
each sample was aliquotted into a 96-well plate in triplicate. To the samples was added 50 μL 
of sulfonamide solution prior to incubation for 10 minutes in the absence of light at room 
temperature. Using a multichannel pipet, 50 μL of NED solution was added to each well and 
incubated at room temperature for 10 minutes in the absence of light. Finally, absorbance 
measurements at 550-nm were taken and nitrite concentration determined from a standard 
curve. 
Results 
 No changes in nitric oxide levels were observed in any of the treatment or control 
groups throughout the course of the experiment. All values observed were below the 
detection limits of the assay used throughout the entire course of the experiment. Figure 2.3 
shows the results of the NOS assay over the time-course of the experiment. Cells were 
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checked for viability and no significant reduction in cell viability was noted in any of the 
groups. 
 
Figure 2.3: Plot of nitrite vs. time for conditioned media from in vitro study. A plot of 
the NO concentration (in μM) for various time points throughout the experiment for 
each treatment group. All points are below the detection limit of the reaction (2.5 μM) 
used in this experiment. 
Discussion 
 The results observed in this experiment bring in to question several previously 
observed results in literature. Specifically, in cell cultures of the size studied herein and of 
those studied in the literature one might question the appropriateness of using the Griess 
reaction to monitor nitrite levels. Specifically, previously reported values in literature are at 
or below the reaction detection limit for the Griess reaction. However, assuming the Griess 
reaction is sensitive enough to detect such small levels of NO as would be produced in the 
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cell culture environments used herein and in the literature, several alternative explanations 
exist for the discrepancies observed. 
 One possible explanation for the results observed is that the ICES stimulation 
protocols used in this study are significantly different from those previously studied in the 
literature. Perhaps the ICES protocol employed herein is not as effective at stimulation at the 
given dose as previously studied protocols. The result may be that the ICES stimulation used 
in this experiment does not result in significant increase in NOS activity or NO production. 
Alternatively, one might expect that there is a possibility that our ICES protocol does not 
stimulate the same Ca/CaM dependent NOS pathway—leading to a complete lack of 
difference in NO production between groups. 
Ultimately, the goal of ICES is to help alleviate pain and inflammation. There are 
several pathways yet to be discussed that are directly involved in pain and inflammation—for 
example, the arachadonic acid pathway, a prominent and important pathway involved in 
many different inflammatory effects. Since in vitro studies often fail in their ability to 
translate directly to the clinic, it is important that future studies seek either translation of the 
in vitro results or focus on animal and human studies. In order to establish the efficacy of 
ICES as an anti-inflammatory, it is perhaps most pertinent to consider animal studies. A well-
established model of inflammation, such as the carrageenan foot-pad edema model, should be 
chosen and the efficacy of ICES on such a model tested. Only then is there reasonable 
evidence to support further exploration of possible mechanisms. 
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CHAPTER 3 : ICES AS A MEANS OF ACUTE INFLAMMATION REDUCTION 
Overview 
 Inductively coupled electrical stimulation (ICES) has been implicated as an effective 
means of treating various maladies, including inflammation. In this study we used a 
carrageenan footpad edema (CFE) model in the rat to examine the anti-inflammatory effects 
of 40 T/s ICES. Inflammation was measured using plethysmometry and the circulating 
inflammatory factors interferon-gamma (INF-γ), interleukin-1-beta (IL-1β), and interleukin-6 
(IL-6) were monitored. We found significantly reduced (31.8%, P <0.01) disease burden 
measurements in groups treated with ICES compared to controls as measured using 
plethysmometry. However, circulating inflammatory factors did not show statistically 
different levels in any of the groups as compared to the negative control. 
Introduction 
Various sources in the literature have strongly supported the ability of ICES to reduce 
acute inflammation
10,11
. Specific inflammatory factors, such as IL-1β, have been implicated 
in the anti-inflammatory effects of ICES
4,6,7,10,18,19
. To our knowledge, very few studies have 
been conducted which make use of CFE to study ICES efficacy
104
, thus we implement the 
use of plethysmometry to track paw inflammation volume. The CFE model is an acute 
inflammatory model which makes use of an injection of the algal-derived sulfonated 
polysaccharide λ-carrageenan to induce a well understood inflammatory response in the 
footpad of a rat
83,84
. Typically the inflammation volume can be tracked using paw volume 
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measurements (plethysmometry). Inflammation in the CFE model typically resolves 
spontaneously within 8-12 hours in untreated animals. Additionally, significant reduction in 
inflammation can be achieved using dexamethasone as a positive control. Thus, CFE 
provides an easily modulated model to testing the efficacy of anti-inflammatory therapeutics. 
The goal of this study is to establish the baseline efficacy of ICES as an anti-inflammatory 
therapeutic in order to outline dosing experiments as well as future experiments that could 
lead to the determination of specific mechanisms by which ICES works. 
Materials and methods 
Animals 
 This study made use of 6-8 week old adult male Sprague-Dawley rats that were given 
access to food and water ad libitum. ICES treatment was provided external to the cages in 
order to leave the animals undisturbed during the experiment. At the terminus of the 
experiment animals were anesthetized according to IACUC-approved protocols. All 
measurements and treatments were given in accordance with IACUC-approved protocols. 
ICES instrumentation 
In order to leave animals undisturbed during their treatment, a customized stimulation 
mat was developed which housed paired coils of alternating orientation so as to reduce 
destructive interference. The mat was placed underneath the cages of the animals with 
driving electronics to the side of the mat. The mat consisted of custom-wound, square-shaped 
coils laid in a pattern of alternating polarity (Figure 3.1). The stimulation protocol provided 
peak stimulation of 40 T/s magnetic flux change through the volume occupied by the animal. 
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Figure 3.1: Image of the mat-style ICES stimulation unit (Left) Representative drawing 
of the alternating coil pattern which provided uniform stimulation through closed 
magnetic loops. Arrows indicate direction of current flow through coils, x’s represent a 
magnetic field pointing into the page, dots represent magnetic field lines coming out of 
the paper. (Right) Image of the actual setup upon which the cages were housed. Note 
that the drawing shows only a partial array of the 3x6 coils in the plane, whereas the 
actual test instrument had an array of 4x8 coils, as indicated in the photograph to the 
right. Instantaneous magnetic flux alternated between adjacent and diagonal coils in 
much the same way as dark and light squares alternate on a checkerboard. The 
electromagnetic pulses were applied only for 100 μs per pulse, and pulse polarity was 
alternated between pulses so the direction of the magnetic flux toggled from on 
direction to the other with each polarity reversal. 
Treatment groups 
In this study, 30 animals were divided into 3 groups of 10. The negative control group 
received per os (PO) PBS, the positive control group received a 3 mg/kg (PO) dose of 
dexamethasone, and the remaining group was exposed to 40 T/s ICES with the following 
stimulation parameters: 
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Waveform shape: trapezoidal 
Rising/falling edge slew rate: 40 T/s 
Pulse width: 100 μs 
Pulse rate: 5 pps 
Duty cycle: 0.0001s/0.2s = 0.05% 
Stimulation length: Continuous while animals were in their cage. 
Groups are displayed below in Table 3-1, which summarizes groups and dosing. 
Animals were exposed to their respective treatments one hour prior to CFE induction—ICES 
stimulation continued throughout the duration of the experiment. 
Table 3-1: Dosing chart for ICES CFE study. Group 1 received PO PBS as a negative 
control. Group 2 received 3 mg/kg PO dexamethasone as a positive control. Group 3 
received 40 T/s ICES does via the mat-style unit. All animals received carrageenan in 
their right hind paw and a saline injection for the left hind paw. 
Group # N Treatment Dose Route 
1 10 PBS N/A PO 
2 10 Dexamethasone 3 mg/kg PO 
3 10 ICES 40 T/s External 
Totals: 30    
 
 67 
 
Carrageenan challenge/CFE induction 
 One hour post-treatment, carrageenan footpad edema was induced in the right hind-
paw of adult rats by injecting 0.1 mL of 1% carrageenan in saline. The contralateral limb was 
used as a control by injecting 0.1 mL of sterile saline into the footpad. 
Plethysmometry measurements 
 A plethysmometer (PVP1001, Kent Scientific Corporation, Connecticut, USA) was 
used to measure change in paw volume as an indicator of inflammation. Inflammation from 
CFE is reported as a difference between right (carrageenan) and left (PBS control) paw 
volumes for each animal. Plethysmomemtry measurements were taken prior to carrageenan 
administration (0 hours), and then 1, 2, 4 and 8 hours post-carrageenan administration 
according to methods established by the Charles River Laboratories (Wilmington, MA). 
Circulating inflammatory factor measurements 
 Concentrations of interferon-gamma (INF-γ), interleukin-1-beta (IL-1), and 
interleukin-6 (IL-6) were monitored to determine how select inflammatory factors were 
affected by ICES treatment. To measure the inflammatory factor levels, 0.2-mL blood 
samples were drawn sublingually under no anesthesia at 1 and 8 hours post-carrageenan 
administration in animals 1-5, and at 4 hours in animals 6-10 in each treatment group. 
Results 
Plethysmometry 
 Edema (i.e. CFE) was calculated as the difference between right and left hind paws 
for each animal at each time point. A plot of the 8-hour CFE time-course is shown in Figure 
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3.2. Groups treated with dexamethasone (3 mg/kG) had a disease burden reduction of 63.2% 
(P < 0.001) with respect to saline controls. Significance is based on two-way repeated 
measures ANOVA with a post-hoc Bonferroni test. Significance was observed in all time-
points after 1 hour for dexamethasone as compared to PBS. Significance was observed in all 
time-points after 2 hours for 40 T/s ICES as compared to PBS.  
  
Figure 3.2: 8-hour CFE time-course summary of inflammation.  PBS, Dexamethasone 
(3 mg/kg) and 40 T/s ICES treatment are shown as diamonds, squares and triangles 
respectively. Significance: *=P<0.05, ***=P<0.001. 
 From the 8-hour time course, one can calculate the total disease burden, which is the 
area under the CFE time-course curve. This calculation is performed as a discrete integral 
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using the average value between time points (middle-sum discrete Riemann integral). It 
should be noted that each data point in a CFE curve is corrected by subtracting the baseline 
initial CFE volume for the given treatment group from all subsequent time-points. A plot of 
the total 8-hour disease burden is shown in Figure 3.3. Significance in disease burden was 
observed in both dexamethasone (1.25 + 0.15 mL-h, P<0.001) and 40 T/s ICES groups (2.32 
+ 0.28 mL-h, P<0.01). Significance was also observed between the dexamethasone and ICES 
group (P<0.005). 
By comparing disease burdens to the PBS negative control, disease suppression can 
be calculated as a percent difference between the given treatment and the PBS control. The 
explicit calculation is given as: 
    
         
     
   
   
     
       (2) 
 Disease suppression is shown for the dexamethasone positive control and the 40 T/s 
ICES treatment in Figure 3.4. Dexamethasone showed 64% disease suppression while ICES 
showed 32% disease suppression.  
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Figure 3.3: 8-hour total disease burden for ICES CRF study. Disease burden represents 
the base-line corrected area under the CFE curve for each group. Lower disease burden 
values correspond to a more positive outcome. Groups (left to right): PBS negative 
control, dexamethasone positive control (3 mg/kg), and ICES (40 T/s). Significance: 
**=P<0.01, **=P<0.001 as compared to PBS negative control. +=P<0.005 as compared 
to dexamethasone positive control. 
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Figure 3.4: 8-hour disease suppression for ICES CFE study. Disease suppression, 
calculated from disease burden, represents the percent difference between a given 
treatment and the PBS negative control. Groups: (left) Dexamethasone (3 mg/kg); 
(right) 40 T/s ICES. Larger values are considered a more positive outcome.  
Cytokine concentrations 
 No significant differences were observed in cytokine levels across groups. Values 
presented as 4.9 with no error bars are considered to be below detectable limits for the given 
assay and represent values that were less than 50% of the lowest concentration on the 
standard curve (9.8 pg/mL). Figure 3.5, Figure 3.6, and Figure 3.7 represent the 8-hour IFN-
γ, IL-1β and IL-6 summaries respectively. 
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Figure 3.5: 8-hour summary of IFN-γ concentration in CFE-induced rats. No 
significance found using two-way ANOVA with Bonferroni test as compared to PBS 
negative control. 
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Figure 3.6: 8-hour summary of IL-1β concentration in CFE-induced rats. No 
significance found using two-way ANOVA with Bonferroni test as compared to PBS 
negative control. 
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Figure 3.7: 8-hour summary of IL-6 concentration in CFE-induced rats. No significance 
found using two-way ANOVA with Bonferroni test as compared to PBS negative 
control. 
Discussion 
 The plethysmometry data supports our hypothesis that ICES is an effective treatment 
for reducing acute inflammation. Significant differences in CFE were observed between both 
dexamethasone and ICES treatment as compared to PBS negative controls. This observation 
strongly supports the hypothesis that ICES is an effective anti-inflammatory therapeutic. 
Furthermore, a significant difference was observed between ICES and dexamethasone which 
implies that the two may have different mechanisms of action, or that there is a dose-
response associated with ICES. It is apparent that future work should focus on determining 
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the dose-response of ICES as this will most certainly assist in determining what type of 
mechanism is involved in the anti-inflammatory effects observed. 
 Circulating cytokines were not significantly different between any of the groups. One 
possible explanation for this observed behaviour is that the specific cytokines examined 
(IFN-γ, IL-1β and IL-6) are associated more strongly with chronic inflammation than with 
the acute inflammation response. Perhaps a more telling indicator of the anti-inflammatory 
effects of ICES would be to examine histological differences between ICES, PBS and 
dexamethasone. Since dexamethasone specifically blocks production of both lipoxygenase 
(LOX) as well as cyclooxygenase (COX) at the cellular level, it inhibits the recruitment of 
many more inflammatory cells than an anti-inflammatory agent that inhibited only one of the 
two
105
. Significant differences between ICES and PBS might be expected in neutrophil 
infiltration if, for example, ICES inhibited the LOX pathway—however, if ICES inhibited 
COX and not LOX, or neither, then neutrophil infiltration would expected to be significantly 
different from the positive dexamethasone control but not from the negative control. 
Furthermore, additional factors, such as platelet activating factor and NOS levels could be 
monitored in future work to determine if alternative (non-COX/LOX) pathways could be 
affected. Literature strongly suggests that involvement of NOS modulation as the primary 
mechanism by which ICES functions
7,10,11,19
. However, our previous in vitro work has called 
these NOS pathways into question. Another consideration to be made is the fact that initial 
inflammatory response is typically triggered by binding of pathogen associated molecular 
patterns (PAMPs) to pattern recognition receptors (PRRs) on the surface of immune cells. It 
is possible that the triggering of PRRs is inhibited or modulated by the presence of ICES 
stimulation—either molecular binding or down-regulation of PRR expression. Because 
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protein expression could be modulated by ICES to cause a change in molecular patterns, it’s 
important that future work also include the potential to examine gene and protein expression. 
 ICES is herein verified as an effective means for reducing acute inflammation. Future 
work should focus on determining mechanism, dosing and safety. Such work can be done as 
dose-response studies that monitor histology and protein expression. Safety should also be 
studied in an effort to determine any side-effects that might be caused by ICES. Dose-
dependence may shed light on the potential mechanisms as certain pathways are more 
effective at reducing swelling than others. If ICES can be further studied and understood, it 
may provide an alternative therapy for those requiring anti-inflammatory therapy while also 
furthering the understanding that we have of basic human physiology and electrophysiology. 
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CHAPTER 4 : ICES DOSE-RESPONSE IN CFE REDUCTION 
Overview  
Previous work has shown that a significant reduction in inflammation can be achieved 
by using low-dose inductively coupled electrical stimulation (ICES) in the acute carrageenan 
footpad edema (CFE) model. Presently we seek to investigate the possibility that ICES may 
have a dose-dependent response. We treated CFE-induced rats with 40, 80, 120 and 160 T/s 
ICES treatment provided by a custom-made stimulation unit meant to mimic sub-threshold 
in-vivo electrical patterns. Significant reduction in CFE at various sample times was 
observed in ICES treatment groups. Significant reduction in 8-hour disease burden was 
observed in all ICES treatment groups and significant 4-hour disease burden reduction was 
observed in all but the 80 T/s ICES treatment groups. While significant differences were not 
observed between treatment groups in terms of inflammation reduction, the data trends 
towards a dose-dependent response for ICES. Our data and observations herein confirm that 
ICES holds the potential as an extremely effective anti-inflammatory treatment that 
ameliorates the need for ingested, liver-dependent anti-inflammatory drugs. 
Introduction 
 Our previous research, and the research of others, has strongly suggested that ICES is 
an emerging therapy that provides significant inflammation reduction
1,3,10,11,22,49,56,64,106,107
. 
Specifically it has been shown that ICES, using the appropriate stimulation parameters, can 
provide significant reduction of inflammation in the acute rat CFE model. Such reduction in 
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inflammation has been achieved with levels as low as 40 T/s peak field strength. ICES is a 
poorly understood and researched therapy—a vast majority of the literature fails at least one 
of the fundamental requirements of the scientific paradigm. The two most frequently 
observed downfalls of ICES research in our observation are improper or non-existent 
controls and failure to provide repeatable results
1
. For the very reason that the majority of 
ICES research has been poorly handled by the scientific community on the whole, there is a 
large amount of doubt and healthy skepticism that has emerged over time in the general 
populations’ understanding of electromagnetic therapies. Thus, we have elected to perform 
research in as controlled a manner as possible, to the highest achievable scientific standards, 
so as to eliminate any bias, errors, or confounding variables that could negatively affect the 
quality of our measurements. In order to achieve such high quality research, the very well-
established rat CFE model was chosen as the acute model of inflammation to study. 
Furthermore, expertise in working with the CFE model was sought out and the experiments 
run locally at a contract research organization with significant CFE experience. 
The CFE model is a very well established method for studying acute inflammation. 
The model operates by injecting lambda carrageenan into the hind foot pad of adult Sprague-
Dawley rats. The injection causes a biphasic response: an early, trauma-induced, non-
phagocytic immune response (NPIR) and a later, phagocytic immune response (PIR). The 
NPIR is hypothesized to result from the trauma associated with the injection, while the PIR is 
associated with the immune response caused by the carrageenan itself
83,84
. The PIR is marked 
by infiltration of neutrophils into the tissue, swelling, edema, redness and pain. Additionally, 
the CFE model responds reliably and repeatably to steroidal and non-steroidal anti-
inflammatory drugs (SAIDs and NSAIDs) which block the arachadonic acid pathways 
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associated with COX-1 and COX-2. Thus, a positive control can be implemented as a 
comparison for inflammation reduction. The CFE model is an acute model that 
spontaneously resolves in most animals over the course of 8-12 hours—with peak CFE 
inflammation occurring around 4 hours in most cases. 
 To test the efficacy of ICES in reducing inflammation in the CFE model, it is 
important to consider the potentially effective stimulation protocols. ICES protocols are even 
more poorly understood from a mechanistic standpoint than from an efficacy standpoint. 
Thus, in determining potentially effective treatment regimes, we explored the gambit of 
physiologically relevant signals that might be produced. Tissues in the body are constantly 
exposed to a variety of internally and externally developed electromagnetic fields. Some of 
these fields are strictly electric (DC E-fields), some are strictly magnetic (DC B-fields) and 
some are electromagnetic (A/C B-fields and E-fields). If one removes the veritable ocean of 
man-made electromagnetic stimulation provided by information and power transmission, one 
is left with only a small number of externally generated stimuli to which the body is exposed: 
Earth’s magnetic field, electric fields generated by natural phenomenon (lightning, etc.), light 
from the sun and high-energy cosmic rays. Evolution naturally selects for physiological 
development that favours those who can survive in such conditions. Thus, it follows that the 
body should either ignore the signals completely, or use them to adapt. Given that there is 
little evidence to suggest that, with the exception of light from the sun, the body uses any of 
the aforementioned signals to survive or adapt, one must turn to the electromagnetic stimuli 
developed internally as a potential source to which tissues might respond. It is well 
established that in the absence of signals perceived as “normal,” tissues will begin to shift 
from homeostasis. In extreme conditions, such as loss of efferent nerve connection to a 
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muscle, tissues can begin to atrophy or even necrose in the absence of normally perceived 
signals. Most internally developed fields are set up by nerves, muscles and bones in the 
body
108,109
. Such internally evolved fields can be considered to be a part of the homeostatic 
conditions in which tissues exist under normal, healthy conditions. Striving to maintain 
homeostatic electrical conditions would thus seem to be a potential method to reduce 
inflammation as it could help “trick” tissues into experiencing normal conditions and reduce 
the quantity of pro-inflammatory factors released or recruited. Therefore, our stimulation 
regimen is based upon field intensities and durations that are known to be native in the in 
vivo scenario while generally being absent from natural external ambient electro-magnetic 
fields. 
There it very little rational basis upon which to suggest that a static magnetic field 
should have any effect on tissues. Specifically, the only physical arguments that might be 
made for a static magnetic interaction would, by necessity, be based on para and 
ferromagnetic particles in the body, the Hall Effect, or modification of Larmor procession. 
Paramagnetic and ferromagnetic materials do exist in the body. In fact, some complex 
animals are hypothesized to have specific structures to explain their ability to orient and 
navigate along the earth’s magnetic field lines by means of magnetoception. Some 
microorganisms such as magnetotactic bacteria are known to harbour particles specifically to 
allow organization and orientation along magnetic field lines. However, there is very little 
literature to suggest that musculoskeletal tissues or other structural tissues of the body 
interact strongly enough with magnetic fields to produce measurable effects. Furthermore, 
there is no evidence to assume that tissues require static magnetic stimulation in order to 
survive—this is partially because no observations have been made that suggest that there are 
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any negative effects of removing a human from the earth’s magnetic field. Furthermore, the 
body does not generate its own magnetic fields on a large enough scale that they would be 
significant as compared to thermal noise or the earth’s magnetic field. There is a large 
amount of evidence that suggests that tissues require and generate their own electric fields in 
order to function and survive. From a physics standpoint, there are two simple ways of 
developing an electrical field: by direct (capacitive) electrical stimulation and by induced 
(inductive) electrical stimulation. Capacitive fields are prone to dangerous arcing, 
manipulation by metallic and conducting objects and pose the issue of providing current flow 
along a path of least resistance: this can cause over stimulation of a small area of tissue and 
under-stimulation of the large volume of surrounding tissues. Inductive methods, however, 
make use of rapidly changing magnetic fields—a type of magnetic stimulation by which any 
charge conducting materials could potentially be affected. Specifically changing magnetic 
fields have the ability to induce an electromotive force that can drive a current and produce 
an electric field. Thus, it is possible to introduce electric fields into the body by using 
inductive methods: this is precisely the theory of operation for ICES. 
Materials and methods 
Animals 
This study made use of 6-8 week old adult male Sprague-Dawley rats that were given 
access to food and water ad libitum. Animals were housed in modified cages that were 
approved for use by an IACUC. Briefly, cages contained an insert that reduced livable floor 
area to 4”x 16”—this design allowed for enough room for an animal to move properly, while 
also providing a controlled space in which to achieve appropriate ICES dosing (Figure 4.2). 
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Animals were housed with one animal per cage in order to ensure comfort and room to turn 
around. At the termination of the study, animals were anesthetized to collect sample tissues 
according to IACUC-approved protocol. 
 
Figure 4.1: Image of the mat style ICES treatment unit. (Top) A cartoon describing the 
direction of current flow in coils. Dots represent magnetic field lines pointing “out” of 
the page; x’s represent magnetic field lines pointing into the page. (Bottom): a 
photograph of the ICES mat setup showing driving electronics on the left and the mat 
surface to the right. 
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Figure 4.2: Depiction of cage-insert style ICES stimulation unit. (Top left) A 3-D 
representation of the cage inserts for the ICES units. The oblong disks represent coils 
or dummy coils used in the experiment. The animal is housed between the two plates 
upon which coils are mounted. (Top right) An actual image of the ICES insert used to 
provide high-dose treatment. (Bottom left and right) Side and top views of the actual 
ICES cage insert used to deliver treatment to CFE animals. 
ICES treatment units 
 ICES was provided by two different types of setups. One was an external mat that 
was designed to provide even, low-dose stimulation (40 T/s) over the surface of the base of 
the cage (Figure 4.2). In this first setup, cages rested on top of the stimulation mat and an 
insert was placed into the cage to provide volume control that was the same as the volume 
control in the higher dose units. The higher dose units contained an insert that housed all 
electronics and stimulation coils (Figure 4.2). The high-dose units were capable of delivering 
stimulation levels of 40, 80, 120 and 160 T/s. Due to space and time restrictions, the high-
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dose units were used only for the 80, 120 and 160 T/s treatment groups. The treatment units 
delivered three types of pulse stimulation protocols. These three protocols are shown in 
Figure 4.3. 
 
Figure 4.3: Graphical representation of the electrical stimulus travelling into the ICES 
coils used in this study. Figure is not to scale. Pulse widths are 100 µs wide. 
Treatment groups 
Animals were divided into 10 treatment groups, summarized in Table 4-1 below. One 
hour prior to CFE induction, animals were exposed to their respective treatment. Negative 
control was provided by a per os (PO) dose of phosphate buffered saline (PBS). Positive 
control was provided by a 3 mg/kg dose (PO) of dexamethasone. ICES treatment was 
provided at four various intensities: low (40 T/s), Medium (80 T/s), High (120 T/s), and 
Extra High (160 T/s). Groups are displayed in Table 4-1 below which summarizes groups 
and dosing. Animals were exposed to their respective treatments one hour prior to CFE 
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induction—ICES stimulation continued throughout the duration of the experiment. It should 
be noted, that for groups 7-10, the experiment was terminated at the 4 hour time point to 
provide a comparison to the 8 hour time point for the ICES low and ICES extra high animals.  
Table 4-1: Dosing chart for CFE dose-response study. 
Group # n Treatment Dose Route 
1 10 PBS N/A PO 
2 10 Dexamethasone 3 mg/kg PO 
3 10 ICES Low 40 T/s External 
4 10 ICES Medium 80 T/s External 
5 10 ICES High 120 T/s External 
6 10 ICES Extra High 160 T/s External 
7 6 PBS N/A PO 
8 6 Dexamethasone 3 mg/kg PO 
9 6 ICES Low 40 T/s External 
10 6 ICES Extra High 160 T/s External 
Totals: 84 
    
CFE induction 
One hour post-treatment, carrageenan footpad edema was induced in the right hind-
paw of adult rats by injecting 0.1 mL of 1% carrageenan in saline. The contralateral limb was 
used as a control and 0.1 mL of saline was injected into the footpad.  
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Plethysmometry measurement 
A plethysmometer (PVP1001, Kent Scientific Corporation, Connecticut) was used to 
measure change in paw volume as an indicator of inflammation. Inflammation from CFE is 
reported as a difference between right and left paw volumes for each animal. Plethysmometry 
measurements were taken prior to carrageenan administration (0 hours), and then 1, 2, 4 and 
8 hours post-carrageenan administration according to methods established by the Charles 
River Laboratories (Wilmington, MA). 
Tissue collection 
At the end of the final time point (8 hours for groups 1-6 and 4 hours for groups 7-
10), animals were anesthetized and tissues were collected. Both hind paws were collected for 
animals 1-6 in each of the groups. Paws from animals 1-3 in all groups were stripped of skin 
and fixed in 10% NBF for subsequent histology while paws from animals 4-6 in all groups 
were snap frozen in liquid nitrogen and stored for future RNA analysis. After a minimum of 
48 hours of fixation, NBF fixed paws were transferred to 20x paw volume of Immunocal 
(Decal Chemical Corporation, Tallman, NY) for decalcification. 
Histology 
Upon completion of decalcification, paws were mounted in paraffin and sectioned in 
the sagittal plane. Three sections from the center of the foot, each 100 µm apart, were 
mounted on slides and stained with H&E for standard light microscopy analysis. Sections 
were visually inspected at high magnification and evaluated for cellular infiltration. 
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Results 
Results of the CFE study are summarized in the tables and charts below. Previous 
work has established that the peak time for inflammation differences between treatment 
groups are the 4 and 8 hour time points. Thus, groups 7-10 were terminated at 4 hours to 
provide limbs for RNA and histology comparison, while groups 1-6 were terminated at 8 
hours in order to provide full time-course CFE profiles. 
Plethysmometry 
Edema (i.e. CFE) was calculated as the difference between right and left paws for 
each animal at each time point. A plot of the 4-hour and 8-hour CFE time-courses are shown 
in Figure 4.4 and Figure 4.5 respectively. Significance is based on standard ANOVA. 
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Figure 4.4: 4-hour CFE time-course summary for PBS, Dexamethasone, 40 T/s (ICES 
Low), and 160 T/s (ICES X High). Significance based on two-tailed t-test as compared 
to PBS measurement at the same time point. Significance: *=P<0.05, **=P< 0.005, 
***=P<0.001. 
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Figure 4.5: 8-hour CFE time-course summary for PBS, Dexamethasone, 40 T/s, 80 T/s, 
120 T/s and 160 T/s ICES doses. Significance based on two-tailed t-test as compared to 
PBS measurement at the same time point. 
From the 4 and 8-hour time courses, one can calculate the total disease burden as the 
integral under the CFE time-course curve. This calculation is performed as a discrete integral 
using the average value between time points (Middle-sum discrete Riemann integral). It 
should be noted that each data point in a CFE curve is corrected by subtracting the baseline 
initial CFE volume for the given treatment from all time points in the respective treatment 
group. Plots of the total 8-hour and 4-hour disease burden are shown in Figure 4.6 and Figure 
4.7 respectively. By comparing disease burdens to the PBS negative control, disease 
suppression can be calculated. Disease suppression (Figure 4.8) is calculated as the percent 
difference between the given treatment and the PBS control. The explicit calculation is given 
as: 
    
         
     
   
   
     
       (3) 
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Figure 4.6: 8-hour total disease burden for groups 1-6. Disease burden represents the 
base-line corrected area under the CFE curve for each group. Lower disease burden 
values correspond to a more positive outcome. Groups (left to right): PBS negative 
control. Dexamethasone positive control (3 mg/kg). Low dose ICES (40 T/s). Medium 
ICES (80 T/s). High dose ICES (120 T/s). Extra High dose ICES (160 T/s). Significance: 
*=P<0.05, **=P<0.005, ***=P<0.0005 as compared to PBS negative control. +=P<0.05, 
++=P<0.005 as compared to Dexamethasone positive control. 
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Figure 4.7: 4-hour Disease Burden Summary. Disease burden represents the base-line 
corrected area under the CFE curve for each group. Lower disease burden values 
correspond to a more positive outcome. Significance: *=P<0.05, ** P<0.005, 
***P<0.0005 as compared to PBS negative control. +=P<0.05 as compared to 
Dexamethasone positive control. 
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Figure 4.8: Disease suppression, calculated from disease burden, as compared to PBS 
negative control for each group in the 8-hour CFE time course. Groups (left to right): 
Dexamethasone (3 mg/kg) positive control, Low dose ICES (40 T/s), Medium dose ICES 
(80 T/s), High dose ICES (120 T/s), Extra high dose ICES (160 T/s). Larger values are 
considered a more positive outcome. 
Histology 
Below are representative histological samples from 4-hour time points of the CFE 
study (Figure 4.9). Right hind paws represent carrageenan injected paws, left paws are self-
controls that were injected with saline.  
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Figure 4.9: Sagittal slice of a dexamethasone positive control right hind paw stained 
with H&E. A) View of the entire sagittal section of the paw with the heel facing to the 
right of the image. B) Close-up of the foot pad section showing skeletal muscle and 
connective tissues. C) Magnification of close-up in (B) showing dark stained nuclei, red 
stained muscles and connective tissue showing slight infiltration is seen in this section. 
A 
B 
C 
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Figure 4.10: Sagittal slice of a PBS negative control right hind paw stained with H&E. 
A) View of the entire sagittal section of the paw with the heel facing to the right of the 
image. B) Close-up of the foot pad section showing skeletal muscle and connective 
tissues. C) Magnification of Close-up in (B) showing dark stained nuclei, red stained 
muscles and connective tissue having distinct and heavy neutrophil infiltration in the 
footpad. 
A 
B 
C 
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Figure 4.11: Sagittal slice of a 40 T/s ICES treatment right hind paw stained with H&E 
A) View of the entire sagittal section of the paw with the heel facing to the right of the 
image. B) Close-up of the foot pad section showing skeletal muscle and connective 
tissues. C) Magnification of Close-up in (B) showing dark stained nuclei, red stained 
muscles and connective tissue having distinct and heavy neutrophilic infiltration. 
B 
C 
A 
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Figure 4.12: Sagittal slice of a 160 T/s ICES treatment right hind paw stained with 
H&E. A) View of the entire sagittal section of the paw with the heel facing to the right 
of the image. B) Close-up of the foot pad section showing skeletal muscle and connective 
tissues. C) Magnification of close-up in (B) showing dark stained nuclei, red stained 
muscles and connective tissue as well as very heavy neutrophilic infiltration.  
 
A 
B 
C 
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Figure 4.13: Sagittal slice of a dexamethasone positive control left hind paw stained 
with H&E. A) View of the entire sagittal section of the paw with the heel facing to the 
right of the image. B) Close-up of the foot pad section showing skeletal muscle and 
connective tissues. C) Magnification of close-up in (B) showing dark stained nuclei, red 
stained muscles and connective tissue showing little to no neutrophil infiltration. 
Discussion 
The plethysmometry data supports our hypothesis that the biological response to 
ICES treatment is dose-dependent. Specifically, it appears as if increasing ICES dose 
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provides increasing inflammation reduction. It is difficult to conjecture without further 
research whether or not the dosing plateaus at a particular value. However, it is clear that 
there are significant reductions in inflammation using sub-threshold stimulation provided by 
ICES. From the CFE data plots, it is clear that the highest ICES doses provide consistent 
statistically significant reductions in inflammation as early as 2-hours into treatment which 
persist throughout the remainder of the experiment. Furthermore, it is also observed that even 
the lower ICES doses (40 and 80 T/s) are able to produce statistically significant reduction in 
inflammation as early as 2-hours into the experiment—however because of the large variance 
and smaller relative difference in mean CFE from the PBS control, it is hard to consistently 
observe statistically significant differences in CFE reduction. An interesting consideration to 
make with regards to the efficacy of ICES is the time point at which efficacy may first be 
observed. It is well understood that there are two phases of inflammation associated with 
CFE: the first, immediate inflammatory response is associated with the trauma of injecting 
carrageenan. The second, delayed response is associated specifically with the immune 
response to the carrageenan, and is marked by increased neutrophil infiltration. Because the 
contralateral limb was used as a self-control for each animal and was injected with saline, the 
trauma associated with injection is theoretically subtracted from the CFE. Thus, our 
observations suggest that we are specifically able to inhibit the inflammation associated with 
the acute immune response—this gives insight as to the potential mechanisms. Further 
investigation is required to determine exactly which pathway is being inhibited or stimulated. 
ICES stimulation is designed as a means of mimicking the natural electrical signals that 
tissues normally see, thus it is a distinct possibility that normally unregulated pathways are in 
fact inhibited. A corollary to such a general pathway is that ICES treatment should only be 
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effective in situations where a tissue is under irregular physiological conditions (i.e. 
pathological states). Such a general pathway could also imply that the effects of ICES would 
be naturally asymptotic towards a value higher than dexamethasone. The reason for such an 
asymptotic behaviour is that the effect would not begin until the pathology had started to 
manifest. This situation is analogous to proportional feedback control in an electronic 
system—the result is that the controller reaches an equilibrium point that is different from the 
target value. However, this model is simply a conjecture and is based solely on supposition. 
Perhaps a more telling metric for overall inflammation reduction is the effect of ICES on the 
total disease burden.  
The 4-hour disease burden indicated that all treatment groups, except 80 T/s ICES, 
provided statistically significant reduction in disease burden. Over the course of 8 hours, 
disease burden is significantly different for all ICES treatment groups as compared to the 
PBS negative control. Both the 4-hour and 8-hour outcomes provide strong evidence to 
suggest a dose response. There is no statistical significance between the ICES treatment 
groups, however they do trend toward a dose-response with higher doses providing a more 
effective treatment. The lack of difference between the 120 and 160 T/s stimulation does 
suggest the possibility that there is a dose plateau where additional stimulus would not 
provide a significantly improved outcome—however further research would be required to 
support such a claim. 
The disease burdens for the 120 and 160 T/s treatment groups are not significantly 
different than the dexamethasone positive control but they do indicate a trend towards being 
different. If sufficient data were available and perhaps more information available regarding 
the effects of even higher intensity ICES treatment (above 160 T/s), a solid conclusion could 
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be drawn regarding existence of a dose response. Furthermore, if the response of ICES does 
plateau before becoming equivalent to the inflammation reduction provided by 
dexamethasone, the implication would be that the ICES may work via a different pathway 
than dexamethasone, that the same pathways are less efficiently activated, or that ICES 
operates via some combination of mechanisms including those involved with 
dexamethasone.  A more appropriate method for beginning to determine a mechanism is to 
observe histology. 
The histological sections obtained from the experiment were stained with H&E, thus 
marking cells and nuclei. Dexamethasone is known to stop the production of arachadonic 
acid which leads to downstream reduction in both the cyclooxygenase pathway (associated 
with production of prostaglandins and thromboxanes), as well as the lipooxygenase pathway 
(associated leukotriene production and increased neutrophilic infiltration). From the images, 
it can be seen that the dexamethasone treated groups had visibly reduced infiltration as 
compared to the PBS treatment group. However, it appears as if the ICES treatment groups 
do not have significantly reduced infiltration as compared to controls. 
ICES has repeatedly shown significant inflammation reduction in the acute 
inflammation model. Our results herein suggest the possibility of a dose dependent 
mechanism by which ICES may work while confirming that ICES provides significant 
inflammation reduction. The histological sections collected to not strongly implicate that 
ICES is capable of reducing neutrophil infiltration. Since one of the most strongly involved 
in promoting neutrophil chemotaxis is the LOX pathway, it seems unlikely that ICES 
strongly affects LOX. Furthermore, if LOX is not inhibited, then the arachadonic acid 
pathway must also not be affected. Specifically, phospholipase must remain largely 
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unaffected if the neutrophil levels are not significantly affected. It is possible that ICES is 
capable of modulating levels of nitric oxide, as has been suggested in the literature. Other 
possible mechanisms include reduction of platelet activating factor and cyclooxygenase 
pathway inhibition. Future research should focus on isolating which pathway(s) may be 
inhibited or up-regulated by the effects of ICES by monitoring local and systemic factors 
involved in inflammation. Regardless, ICES promises the potential to serve as an effective 
means of treating inflammation without the use of pro-drugs that can tax the liver or steroids 
which can cause undesirable long-term effects. 
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CHAPTER 5 : SUMMARY, DISCUSSION AND FUTURE WORK 
 The results of the experiments presented herein clearly support the claim that ICES 
holds the potential to ameliorate many inflammatory ailments. Presently it has been shown 
that ICES in doses of 40, 80, 120 and 160 T/s can be effective in significantly reducing acute 
inflammation. The models used in these experiments are very well established as reliable 
methods for gauging anti-inflammatory efficacy. The same models used herein are 
extensively used within the pharma-industry for early screening of potential new anti-
inflammatory drugs. The question of the underlying mechanism, however, still remains 
somewhat elusive. As compared to dexamethasone, ICES does not seem to have nearly as 
strong an anti-inflammatory effect. Dexamethasone is known to act by inhibiting the 
arachadonic acid pathway, which subsequently inhibits lipoxygenase and cyclooxygenase 
pathways, both of which have very strong effects on inflammation. ICES, however, acts via 
an unknown mechanism. Previous authors have reported strong evidence to suggest that 
ICES delivered via PRF acts by modulating calcium binding interactions with calmodulin
7–
9,18,19
. The studies conducted herein were unable to replicate previous in vitro studies that 
implicated the Ca/CaM mechanism; however, it is worth noting that the ICES protocols used 
in the present studies made use of a different stimulation protocol. 
 The question then must be asked as to why the results of the present ICES in vitro 
studies did not concur with previous literature with regards to mechanism. First, and perhaps 
most obvious, is the fact that previously reported results made use of the Griess reaction, 
which is inadequate for detecting the low levels of nitrite reported in the literature, bringing 
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those reported results into question. However, in an effort to exactly replicate previously 
published results reported in literature, the studies herein used the same reaction and noted no 
significant differences in nitrite levels across any of the study groups. A second possibility 
for the disparity is that the stimulation parameters are different enough that perhaps the ICES 
protocols studied herein act via a different pathway. While a disparity in ICES protocols is 
possible, it does not fit with the working theory in the literature which states that tissues 
integrate signals and require rapidly changing magnetic fields to induce electric fields. Thus, 
the PRF used by previous authors should cause similar effects to the ICES protocols used in 
the studies herein presented. Finally, it is possible that the present work or previous work was 
done incorrectly—thus it is important that the present in vitro studies eventually be repeated 
with a more appropriate measure of NOS activity in order to verify previously reported 
mechanistic theory.  
 In conjunction with the in vitro studies presented, in vivo experiments were 
performed. These experiments were able to repeatedly demonstrate significant and consistent 
reduction in swelling in rats run through a CFE challenge. While significance was not 
established from a dose-response standpoint, there is strong evidence to suggest that there is 
trending toward a dose-dependent response for the ICES stimulation protocols used herein. 
An increase in sample size and the use of higher dosages than those used in the present 
studies could help establish whether or not there is a dose-dependent response seen with 
ICES stimulation. Based on the data collected it can also be suggested that ICES efficacy 
may begin to asymptotically approach a plateau at doses above 120 T/s. Additionally, the 
disease burden reduction at the potential plateau doses is less than that observed from 
dexamethasone positive controls, suggesting that ICES either acts via a different mechanism, 
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that it is less effective at stimulating or inhibiting the same pathways as dexamethasone, or 
that it has other as-yet undetected effects that manifest only partially as reduced 
inflammation while operating simultaneously through unrelated mechanisms to reduce pain 
and accelerate healing. In order to completely differentiate ICES mechanism from 
dexamethasone, drugs could be administered that might block the efficacy of ICES but not 
dexamethasone. For example, L-NMMA could be injected locally with carrageenan. If ICES 
acts via a NOS-dependent pathway, it might be expected that the efficacy of L-NMMA 
treated groups would decline as compared to dexamethasone or non-L-NMMA groups given 
ICES. 
 Regardless, ICES holds the potential to drastically and safely improve the lives of 
many who suffer from chronic inflammatory diseases. Future work should focus on three 
main aspects of ICES: Applications, elucidation of the underlying mechanism and safety. 
 From a safety standpoint, ICES delivers an extremely low-power signal to tissues 
such that there have been no noticeable thermal effects. The other two areas of potential 
safety concern involve the effect of ICES on sepsis and the generation or exacerbation of 
tumor growth. For the aforementioned reasons, studies on septic exacerbation, tumorigenicity 
and tumor growth should be carried out. If ICES promotes homeostasis, and if it acts via a 
mechanism that suppresses the immune response, then it is important to understand the 
potential effects on tumor growth. Furthermore, if tissue growth is accelerated by ICES, then 
it is important that clinicians be aware that carcinomas would present a contraindication to 
ICES application. Needless to say, ICES should be tested for safety prior to deployment in 
the clinical setting. 
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 Specific applications will become apparent as mechanism and efficacy is elucidated. 
For example, one specific experiment that should be conducted to determine maximum 
efficacy would be to study the different possible ICES pulse parameters available that still 
provide the same dosing amplitudes as used in the experiments presented herein. For 
example, one might consider differentiating which of the three protocols, if any, used in the 
experiments above is more effective than the others. Alternatively, increasing the pulse 
frequency while maintaining amplitude dosing would provide valuable information regarding 
the power dosing of ICES. 
 For wound healing studies, an animal experiment could be conducted to study the 
formation of myofibroblasts in vivo in the presence of ICES. One would be interested in 
studying the rate at which myofibroblasts are formed, as well as the rate at which α-SMA is 
produced by the myofibroblasts. Markers for both myofibroblast and α-SMA formation are 
well documented in literature
97–99,102,103
, and could be tracked throughout an experiment 
using stained biopsies. Such an experiment would likely use mice or rats. A surgically 
induced incision wound of known length and depth would be made in a location of the 
animal that could be easily monitored, and inaccessible to the animal. Four treatment groups 
could be created: Control (receiving no treatment), dexamethasone, ICES and 
ICES+dexamethasone groups. ICES therapy would be provided by instrumenting cages with 
appropriate coils to provide ICES stimulus approximately equal to those used herein. Wound 
healing rate would be monitored in several ways. At the biochemical and cellular levels, 
wound exudate could be harvested and H2O2 production could be monitored using Ampex 
Red as described by Zhou
110
. Biopsies taken from wound sites could be examined for rate 
and extent of formation of myofibroblasts. Additionally, histology could also be used to 
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determine the amount of α-SMA produced by said myofibroblasts. An increase in H2O2 
would almost certainly imply an increase in intracellular Ca
2+
 levels—an important 
observation to correlate with wound healing rate. NO levels could also be monitored in 
wound exudate using available fluorometric kits from Cayman Chemical. Other 
inflammatory factors could be monitored in similar ways such as described by Rohde et al
10
. 
Wound healing rate could be assessed physically by measuring the size of the wound daily 
(or hourly if necessary) as well as monitoring inflammation (tumor), redness (rubor) and IR 
temperature (Calor), three of the five classic, clinical hallmarks of inflammation. If the 
aforementioned mechanisms are true of ICES, then one would expect that ICES could 
enhance the wound healing rate, and possibly reduce scar formation. In order to examine 
specific pathways, inhibitors of specific enzymes (such as eNOS) could be added to 
selectively inhibit specific steps in the proposed mechanism. L-N-monomethyl arginine (L-
NMMA) is a common inhibitor of eNOS and nNOS, and could be added to test whether NO 
production in the cells (NOT mitochondria) affects wound healing in the presence of PEMF 
or dexamethasone. 
Perhaps the most revealing wound healing experiments to perform would be to 
modify those performed by Hinz et al
97,98
. Collagen or silicone gels of varying stiffness could 
be made in order to produce the necessary environment for hosting primary lung and 
subcutaneous fibroblasts. Previous experiments have shown that there is a marked difference 
in wrinkle formation between high α-SMA (lung fibroblasts) and low α-SMA (subcutaneous 
fibroblasts) staining cells on high-stiffness gels
98. It has been shown that α-SMA contraction 
strength is limited by calcium levels, however, it has also been shown that if the Ca
2+ 
concentration is changed transiently, that the force developed also changes transiently
99
. 
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Additionally, it has been shown that myofibroblast formation can be induced in vitro using 
TGF-β1—thus if an appropriate model could be developed, then myofibroblast contraction 
force could be measured directly in vitro. All of the same assays could be carried out for the 
collagen/silicone matrices as were done for the in vivo studies. Specifically, H2O2 
production, NO production, and α-SMA staining could all be assessed. Furthermore, 
micrographs of collagen and silicone matrices could be examined for deformation and 
quantified optically or using ESEM. Finally, a measure of cellular contraction could be 
useful to determine the forces imparted on the fibroblasts themselves. Specific inhibitors of 
enzymes could be added as challenges to determine exact pathways. Treatment groups for 
therapy could be divided into groups as in the in vivo studies: negative controls (pathway 
inhibitory drugs), positive controls (pathway stimulatory drugs), and ICES. According to 
Tomasek et al, the approximate force developed across a collagen matrix of an appropriate 
length (unfortunately, the relevant size info is not given, making the stress/strain impossible 
to determine) by protomyofibroblasts and myofibroblasts rises from 0 to approximately 200 
dynes (2 mN). This force can readily be measured using an appropriate strain gauge
99
. 
Various challenges, such as calcium, nitric oxide, as well as inhibitors could be added in 
order to examine the effects of various pathways on the force developed. If ICES does 
operate via calcium-dependent mechanisms, then one might expect that in the presence of 
low-calcium levels, contraction strength of the myofibroblasts would increase measurably in 
the presence of ICES as compared to negative controls. 
From a neurological standpoint the first, and perhaps most obvious, experiment to test 
peripheral interaction of ICES with neurons would be direct electrode measurements. Under 
conditions of ICES, direct measurement of resting membrane potential, depolarization 
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potential, and the characteristics of each including repolarization could be measured. A 
change in the rate of repolarization, depolarization or resting membrane potential could then 
be directly detected for both myelinated and unmyelinated cells. Patch clamp experiments 
could also be used to elucidate the behaviour of ion channels in the presence of ICES. Direct 
electrical measurements could also be taken centrally—however since one might be 
interested in whole groups of neurons, imaging might be a more appropriate modality for 
studying central mechanisms. 
Several imaging experiments come to mind when considering peripheral ICES and 
the effects on the CNS. First, fMRI, PET and optical imaging could all be used to explore 
stimulation of peripheral nerves in animals and humans. By stimulating far enough away 
from the imaging unit (for example, on the foot), one could examine the effects of ICES on 
the brain as a whole. If nociceptive nerve activation was being studied, then an experiment 
on squirrel monkeys could be done using ICES in conjunction with a nociceptive stimulus on 
the hand. Because previous studies have shown very specific interactions between areas 3b/1 
and 3a with respect to nociceptive afferent input
87
, one could easily compare results. 
Furthermore, a contralateral limb (or perhaps even the same limb) could be used as a control 
to examine the differences between ICES and non-ICES stimulated nociceptive and 
mechanical stimuli. If, for example, ICES mostly affected un-myelinated nerves, then that 
might explain the apparent reduction of pain in patients suffering chronic pain (often 
associated with C fiber or central mechanisms). Activation or inhibition in area 3a might be 
indicative of such a mechanism if it was seen under ICES stimulation conditions while 
delivering a noxious stimulus to an animal. Furthermore, if behaviour in 3b/1 was 
unchanged, it might suggest that myelinated nerves are relatively unaffected by ICES. 
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In the case of ICES, since it is applied peripherally, it is essentially implied that 
central mechanisms will only play a role insomuch as they provide processing and feedback 
of the peripherally stimulated/modulated neurons. Thus, conditions that are hypothesized to 
be centrally mediated, such as fibromyalgia, epilepsy, stroke-induced pain, multiple sclerosis 
pain, and spinal cord injury pain, are unlikely targets for ICES therapy. However, clinical 
anecdotal data indicate that ICES is very effective at reducing or eliminating idiopathic 
chronic pain. These data raise the possibility that central mechanisms for interpreting pain 
signals could be modulated or even reset by peripheral and focal use of ICES therapy. It is 
possible that fibromyalgia could be affected by modulating the peripheral signals that are 
processed in areas that affect the locations in the brain that are responsible for fibromyalgia 
pain—however, the exact mechanism(s) of fibromyalgia is not understood. There is evidence 
to suggest that neurogenic urinary incontinence could be a target for therapy (unpublished 
data from Dennis). Application of ICES to the spinal cord region aggravated by inflammation 
has helped relieve urinary incontinence in dogs suffering from arthritis—typically these 
animals have other co-morbidities such as difficulty walking. Interestingly, the comorbidity 
is typically also cured with application of ICES. The exact mechanism by which ICES is 
effective in these situations is still not understood—perhaps being both neurological as well 
as anti-inflammatory in nature. Central lesions or ablations would not likely be candidates for 
ICES treatment as in the situation where 3b/1 is destroyed but 3a spared unless the 
mechanism of action for ICES results in a net attenuation of C fiber activity. 
Peripherally, however, ICES has been shown to be effective in pain management and 
wound healing for both acute and chronic injuries
1,7
. Potentially treatable conditions include: 
wound healing after surgery, chronic pain resulting from inflammatory conditions such as 
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arthritis, and neuropathies resulting from inflammation. An interesting case to consider 
would be phantom limb syndrome. Since phantom limb is hypothesized to be a centrally 
mediated condition, it is unlikely that ICES stimulation of a stump would have any 
significant pain-reducing effects, however, in cases where peripheral nerves are firing 
inappropriately and leading to pain, ICES could potentially be a way to reduce phantom limb 
pain. 
 In terms of future inflammatory studies, several important experiments should be 
performed. As ICES is a candidate for treating and relieving vast numbers of individuals 
suffering from chronic pain, it is of utmost importance to conduct a chronic inflammatory 
study. It is very well understood that different markers and pathways become involved if 
acute inflammation is left unchecked and leads to chronic inflammation. A well-established 
model of chronic inflammation is the rat collagen-induced arthritis model (r-CIA). Such a 
model uses an injection of foreign collagen to induce chronic arthritis in rats. The 
histological, and systemic markers are well studied in the r-CIA model, allowing it to be a 
potentially invaluable model for examining the ability of ICES to relieve chronic 
inflammatory situations. Obviously positive results would strongly indicate the use of ICES 
for individuals suffering from arthritis, as well as many other chronic inflammatory 
conditions. 
 A second inflammatory study to be considered is to examine the efficacy of ICES in 
conjunction with other anti-inflammatory agents. Currently ICES is employed in addition to 
drugs as a mechanism by which to assist with spinal fusion surgeries in patients at high risk 
for non-fusion. ICES may be a useful treatment in conjunction with commonly available 
NSAIDs such as naproxen, aspirin, and ibuprofen. Patients suffering from ailments such as 
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carpal tunnel syndrome, or those suffering sports-related injuries might find relief and 
healing from using ICES in conjunction with NSAIDs. Acute studies could be performed 
using the CFE model to test for the efficacy of NSAIDs with the addition of ICES as a 
treatment supplement. Particularly if ICES can augment NSAID efficacy, the implications 
would be twofold. First, in cases where high NSAID dose is required, ICES could be used in 
conjunction to provide additional alleviation. Furthermore, in patients suffering disorders 
preventing the safe metabolism of pro-drugs (such as those with liver enzyme dysfunction), it 
is possible that ICES could be used to lower the doses of NSAID necessary to maintain 
relief. 
Herein it has been repeatedly and reliably shown that ICES of the appropriate 
stimulation parameters has the ability to significantly reduce acute inflammation. Further 
research holds the promise of expanding the realm of applications for ICES from the acute to 
chronic conditions. ICES holds the potential to reduce inflammation, healing time, scar 
formation and pain in many situations. If applied correctly, researched correctly and 
documented properly, ICES may revolutionize the way in which modern medicine is 
conducted.
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